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A combination of keratinocyte activation with exposure to Th2 interleukins is required to 
alter barrier properties in a reconstructed human epidermis
ÉVELYNE De Vuyst,1 S Giltaire1, 2, A Chrétien,2 C Lambert de Rouvroit,1 M Salmon2 and 
Y Poumay1 1 URPHYM-Medicine, University of Namur, Namur, Belgium and 2 Straticell, 
Les Isnes, Belgium
Etiology of atopic dermatitis (AD) is still puzzling. Interplay between abnormal epidermal barrier 
and T helper type 2 (Th2) immune response is suspected to create vicious circles between both 
components since they induce each other. Transcriptomic studies on keratinocytes after choles-
terol depletion have shown strong similarities with AD deregulated gene expression. Interleukins 
(IL) playing a role in the Th2 immune response such as IL-4, -13 and -25 also altered keratinocyte 
gene expression reminiscent of AD. This study combined endogenous epidermal activation with 
Th2-interleukins to analyze potential synergistic effects on epidermal barrier. Reconstructed human 
epidermis (RHE) were chosen to analyze keratinocytes in tissue-specific context. Their activation was 
initiated by two hours of cholesterol depletion, a condition able to initiate EGFR and p38MAPK-de-
pendent signaling and transiently alter their gene expression. Interestingly, cholesterol depletion 
in mature RHE induced the expression of thymic stromal lymphopoietin which alerts the immune 
system in AD. The effects produced by IL-4, 13 and 25 resulted into AD-specific deregulated gene 
expression of CA2 and NELL2. They also altered RHE morphology as granular layer disappeared, 
intercellular edema developed, and loricrin and filaggrin expression were reduced. Barrier func-
tion was evaluated by trans-epidermal electrical resistance and Lucifer Yellow diffusion through 
RHE. Each treatment alone was unable to alter barrier function. Conversely, cholesterol depletion 
followed by immediate exposure to Th2-ILs resulted into significant alterations of barrier function 
and further reduced expression of keratinization markers. Thus, epidermal or immune activation 
alters keratinocyte within RHE, but combined activation is required to modify the barrier and 
reproduce AD in vitro.    
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A reinnervated skin model: A new tool to study link between innervation and aging
C Jeanmaire,1 C Tedeschi,1 M Chavan,1 L Misery2 and N Lebonvallet2 1 BASF Beauty Care 
Solutions, Essey les Nancy, France and 2 Laboratory of Neurosciences, Brest, France
Epidermis is innervated by sensory fibers that ascend vertically between the keratinocytes toward 
the stratum corneum. This innervation acts directly on epidermal organization and renewal of 
keratinocytes. A skin denervation is sufficient to influence keratinocytes proliferation and therefore 
to decrease epidermal thickness. Furthermore, a decrease of epidermal innervation with aging was 
reported. As epidermal innervation is important for skin homeostasis, we have developed a skin 
reinnervated model based on a co-culture of human skin explant and primary sensory neurons (PSN) 
extracted from dorsal root ganglia of rats. After 10 days of co-culture between skin explant and 
neurons, a dense network of nerve fibers was observed. The histological analysis of skin explants 
has showed differences in the quality of the epidermis between un-innervated (control = skin explant 
without PSN) and reinnervated skin. Indeed, during skin sampling, vascularization and innervation 
were rapidly lost inducing tissue degeneration. So un-innervated skin explants presented damage 
on the epidermis, including vacuolations and acantholysis. By contrast, after skin reinnervation, 
these alterations were less frequent. Furthermore, in the reinnervated skin, less epidermal cells were 
in apoptosis (TUNEL assay) and more keratinocytes were in proliferation (Ki67 labelling) than in 
the un-innervated skin. Finally, measurements of epidermal thickness have showed a significant 
increase of epidermal thicknesses in the reinnervated skin compared to the un-innervated skin. In 
conclusion, thanks to the reinnervated skin model, we have demonstrated that when skin is no 
longer innervated, the epidermis thins to reach the aspect of an aged epidermis. Skin reinnervation 
has allowed reversing the phenomenon. As epidermal innervation decreases with aging, this rein-
nervated skin model is useful to test anti-aging actives.    
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A parathyroid hormone family member TIP39 is expressed in the skin and regulates kerat-
inocyte differentiation
E Sato,1 J Muto,2 L Zhang,1 C Adase,1 JA Sanford,1 RA Lee1 and RL Gallo1 1 Dermatology, 
University of California, San Diego, San Diego, CA and 2 Dermatology, Aichi Medical 
University, Aichi, Japan
Vitamin D acts synergistically with parathyroid hormone (PTH) to increase immune defense but 
the complete roles of PTH and related genes in the skin are unclear. We report discovery of a new 
PTH family member (tuberoinfundibular peptide of 39 residues, TIP39) in human and mouse skin 
and show evidence to suggest that this hormone participates in control of keratinocyte growth and 
differentiation. TIP39 was previously known in the brain to act as a selective ligand for the PTH2 
receptor (PTH2R) but its functions are unclear. We show that TIP39 is also abundant in the skin. 
TIP39 mRNA abundance was similar to brain as measured by qPCR and TIP39 protein was easily 
detectable by Western blot in skin extracts or from culture media of differentiated human kerati-
nocytes (NHEK). Immunohistochemistry detected TIP39 throughout the skin but most abundantly 
in the cytosol of the granular cell layer . However, consistent with its nuclear localization signal 
and hormone function, TIP39 was located in the nucleus of cultured proliferating NHEK cells, in 
basal cell layer of normal skin and in the nucleus of cells in basal cell carcinomas. The expression 
and localization of TIP39 appears to have relevance to the differentiation of keratinocytes as TIP39 
expression shifts to interact with membrane localized PTH2R of basal keratinocytes when they 
undergo calcium induced terminal differentiation. PTH2R expression was constitutively low in the 
squamous cell carcinoma cell line A431 but addition of additional recombinant TIP39 induced 
terminal differentiation of these neoplastic cells. In conclusion, discovery of this PTH related gene 
and its receptor in keratinocytes suggests a previously unknown pathway that influences keratinocyte 
growth and differentiation.    
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Microneedle-mediated delivery of vismodegib across skin
HX Nguyen and AK Banga Pharmaceutical Sciences, Mercer University, Atlanta, GA
Microneedles have been widely investigated as an enhancement technique for transdermal delivery 
of multiple therapeutic agents. In the present study, vismodegib (GDC-0449), a first-in-class, orally 
bioavailable drug for locally advanced or metastatic basal cell carcinoma was used as the model 
drug. The in vitro permeation of vismodegib through dermatomed porcine ear skin was investigated 
after pre-treatment with maltose, poly (lactic-co-glycolic acid) microneedles and Admin PenTM. 
Characterization studies were conducted for microneedle geometry (scanning electron microscopy), 
microchannel dimensions (dye binding, calcein imaging, histology and confocal microscopy studies) 
and the failure of skin integrity due to microneedle insertion (transepidermal water loss measure-
ment). An increase in the needle length from 500 to 1100 and 1400 μm resulted in an enhancement 
of the drug delivery from 14.50 ± 2.35 to 32.38 ± 3.33 and 74.40 ± 15.86 μg/sq.cm respectively. 
The 30-minute post-microneedle treatment equilibration time and the treatment duration (1, 2, 
4 minutes) were found to affect vismodegib permeability. The drug formulation was found to be 
non-irritant by the skin irritation test on in vitro reconstructed human epidermal model EpiDerm 
(the relative tissue viability was 97.1 ± 1.44 %). Changes in microneedle length, equilibration time 
and treatment duration altered the transdermal delivery of vismodegib.    
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Ethnic differences in skin hydration and barrier function, as illustrated by facial mapping
R Voegeli,2 AV Rawlings,1 P Seroul3 and B Summers4 1 AVR Consulting Ltd., Northwich, 
United Kingdom, 2 DSM Nutritional Products Ltd., Kaiseraugst, Switzerland, 3 Newtone 
Technologies, Lyon, France and 4 Photobiology Laboratory, Medunsa Campus, Sefako 
Makgatho University, Medunsa, South Africa
The purpose of this study was to create for the first time detailed maps of hydration and barrier 
function of the entire face in subjects of different ethnicities. Stratum corneum (SC) capacitance and 
TEWL were measured on 30 pre-defined sites on one facial side of subjects of four different ethnici-
ties: Chinese, Caucasians, Indians and Black Africans. In order to limit the biological heterogeneity 
we chose young female subjects having normal skin, without visual signs of photoaging, living in 
Pretoria, South Africa. Hydration and TEWL maps were generated by combining digital images 
and the bio-instrumental data. An algorithm was developed which computes the measured values 
for capacitance and TEWL data and interpolates them as a graded color scale on the images, i.e.as 
full, continuous facial color maps of skin hydration and TEWL. The complexity of facial hydration 
and barrier properties in the ethnic groups is clearly visible in these unique images. On some areas 
of the face, subtle differences were found but in others there were steep particular gradients within 
short distances. The gradients are distinctive in the different ethnic groups. When considering 
the overall ethnicity and overall SC barrier properties, TEWL values (g m-2 h-1) were greatest for: 
Indians (20.4±2.6) > Chinese (18.6±3.5) > Black Africans (16.7±1.6) > Caucasians (12.4±2.4), with 
the Chinese group showing the most complexity. However, overall skin hydration values, shown 
as Corneometer readings (AU) were greatest for: Black Africans (55.0±1.3) > Indians (51.0±2.7) 
> Caucasians (46.8±1.2) > Chinese (41.5±3.1). In contrast to other reports, we found that darkly 
pigmented skin does not always have a superior barrier function and skin hydration is complex. 
Moisturizing concepts, therefore, need to consider the different characteristics of various facial 
anatomical locations as well as the characteristics of different skin ethnicities.    
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Effects of H1-antihistamines on expression of axon guidance molecules in normal human 
epidermal keratinocytes
Y Kamata,1 A Sakaguchi,1 Y Umehara,1 M Tominaga,1 H Ogawa1 and K Takamori1, 2 1 
Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate 
School of Medicine, Urayasu, Japan and 2 Department of Dermatology, Juntendo University 
Urayasu Hospital, Urayasu, Japan
Increased epidermal nerve density is considered as one cause of H1-antihistamine-resistant itch, 
such as atopic dermatitis (AD). Axon guidance molecules, such as nerve growth factor (NGF) and 
semaphorin 3A (Sema3A), play pivotal roles in regulating epidermal innervation. Previously, we 
reported a potential contribution of Sema3A to modulation of epidermal hyperinnervation in AD. 
Previous studies indicated that some H1-antihistamines inhibit neurite outgrowth. However, the 
effects of H1-antihistamines on expression of axon guidance molecules are unknown. Therefore, we 
investigated the effects of H1-antihistamines on axon guidance molecule expression in cultured nor-
mal human epidermal keratinocytes (NHEKs). NHEKs were incubated with various concentrations 
of four H1-antihistamines, i.e., olopatadine, bepotastine, fexofenadine, and chlorpheniramine for 24 
hours at 37°C. After incubation, the cells were harvested, and the mRNA levels of nerve repulsion 
factors (Sema3A and KAL-1) and nerve elongation factors (NGF and artemin) were examined by 
quantitative real-time PCR. Sema3A mRNA level was increased by 50 mM fexofenadine (1.3-fold, 
P < 0.05), whereas the expression was decreased by 50 mM bepotastine (0.8-fold, P < 0.05). KAL-1 
mRNA was increased by 50 mM olopatadine (1.7-fold, P < 0.001), 50 mM bepotastine (1.8-fold, P < 
0.001), and 10 mM chlorpheniramine (1.7-fold, P < 0.001). The level of NGF mRNA was decreased 
by 50 mM olopatadine (0.7-fold, P < 0.001), 50 mM bepotastine (0.4-fold, P < 0.001), and 50 mM 
fexofenadine (0.6-fold, P < 0.001). Artemin mRNA level was decreased by 50 mM olopatadine 
(0.8-fold, P < 0.001), 50 mM bepotastine (0.5-fold, P < 0.001), and 10 mM chlorpheniramine (0.6-
fold, P < 0.001). Thus, the H1-antihistamines examined in this study showed characteristic effects 
on the gene expression of axon guidance molecules in keratinocytes.    
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Network analysis identifies MPZL3 as an essential regulator of epidermal differentiation that 
binds FDXR to induce reactive oxygen species
A Bhaduri,2 A Ungewickell2 and P Khavari1, 2 1 VA Palo Alto, Stanford, CA and 2 
Dermatology, Stanford University, Stanford, CA
To identify novel regulators of epidermal differentiation not highlighted by traditional expression 
analyses, we devised a novel network analysis method that uses the topological constraints of 
scale-free small-world biological networks. A key hub identified was MPZL3, a gene that is highly 
expressed in differentiated human skin though its function is entirely unknown. To characterize 
its role in human epidermis, we depleted MPZL3 in organotypic human skin and found it is an 
essential gene for normal differentiation. To explore its mechanism of action, we fused MPZL3 to 
the BirA* biotin ligase to tag proteins proximal to MPZL3. Mass spectrometry analysis highlighted 
mitochondrial proteins as vicinal to MPZL3. Using cell fractionation, electron microscopy, and 
immunofluorescence we validated MPZL3 mitochondrial localization. Interaction with the top 
hit, FDXR, was confirmed by co-immunoprecipitation and proximity ligation analysis. We demon-
strated that FDXR loss phenocopies MPZL3 in tissue and that enforced FDXR expression rescues 
MPZL3-depletion differentiation defects. Systematic mutagenesis of MPZL3 identified its C-terminal 
low complexity domain as necessary and sufficient for epidermal differentiation and for binding 
to FDXR. FDXR has been described to be required for reactive oxygen species (ROS) mediated 
apoptosis and ROS have recently been described as necessary for epidermal differentiation in mice. 
We observed that depletion of both MPZL3 and FDXR decreased keratinocyte ROS levels and that 
supplementation with galactose oxidase, an enzyme that generates ROS, rescued differentiation 
defects due to MPZL3 and FDXR depletion. We also observed that, while forced expression of FDXR 
in keratinocytes decreases its substrate, NADPH, this decrease is blocked by MPZL3 loss. These data 
indicate that MPZL3 is essential for epidermal differentiation and that it acts with its downstream 
interaction partner, FDXR, to induce ROS.    
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Development of an ex vivo human skin model to study skin barrier repair
T Berkers, L Danso, A Mieremet and J Bouwstra Division of Drug Delivery Technology, Leiden 
Academic Center for Drug Research, Leiden, Netherlands
Currently, no proper ex vivo human skin models are available to study skin barrier repair to screen 
formulations and drugs for enhancing skin barrier repair. The aim of the study was to develop such 
a model based on human ex vivo skin. Stratum corneum (SC) of ex vivo human skin was removed 
by sequential cyanoacrylate stripping. The stripped skin was cultured in an incubator at either 32 
or 37C for 8 days. The number of SC cell layers was examined by safranin staining. Differentiation 
markers and enzymes involved in lipid biosynthesis were examined using immunohistochemistry. 
Thin layer chromatography was used to analyse SC lipid composition. Fourier transform infrared 
spectroscopy was used to examine the lipid organization. After 8 days of culture, explants regen-
erated SC with as similar number of cell layers as in native human SC. At 37°C, the expression of 
epidermal differentiation proteins was similar to that of native human skin with the exception of the 
barrier protein involucrin. At 32°C, early differentiation was delayed, but terminal differentiation 
proteins were similarly expressed as in explants cultured at 37°C. Regarding barrier properties, SC 
lateral lipid organization was less dense in regenerated SC compared to the native SC, but similar 
to that in SC of atopic eczema skin. Additionally, explants cultured at both temperatures showed 
all ceramide classes, but some changes in lipid composition mimic the lipid composition in atopic 
eczema. In conclusion, the removal of SC from ex vivo skin and culture for 8 days at 37°C generates 
an ex vivo human skin model which possesses many similarities in epidermal properties to native 
human skin, but also several important barrier properties mimicking the barrier of atopic eczema 
skin. Therefore this model has the potential to be used in screening formulations and drugs for 
studying skin barrier repair.    
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Lipid chain length reduction correlates with the skin barrier function in atopic eczema 
patients and inflammation plays a role in the altered epidermal lipid biosynthesis
J Van Smeden,1 L Danso,1 M Janssens,1 R Vreeken,1 A El Ghalbzouri,2 S Lavrijsen2 and 
J Bouwstra1 1 Leiden/Academic Center for Drug Research, Leiden, Netherlands and 2 Leiden 
University Medical Center, Leiden, Netherlands
An important feature of atopic eczema (AE) is an impaired skin barrier. The lipids in the stratum 
corneum (SC) lipids – ceramides (CERs), free fatty acids (FFAs) and cholesterol – play an important 
role in the skin barrier function. The aim of the present study was to examine the role of FFAs and 
CERs in the impaired skin barrier function and whether inflammation changes lipid composition in 
SC. In the clinical study the chain length distribution of SC FFAs and CERs and their importance for 
the lipid organization and skin barrier function was examined in AE patients and compared with 
control subjects. A reduction in FFA and CER chain length was observed in non-lesional and lesional 
SC of AE patients. The reduction in FFA chain length associates with a reduced CER chain length, 
suggesting a common synthetic pathway. The lipid chain length reduction correlated excellently 
with an altered lipid organization and an impaired skin barrier function. As changes in lipid chain 
length were more pronounced in lesional skin compared to non-lesional skin in almost all individ-
uals, in a follow up study we examined whether inflammation affects lipid biosynthesis in the skin. 
To examine this we used human skin equivalents and added either pro-inflammatory cytokines or 
Th2 cytokines in the culture medium during culturing. We observed changes in lipid composition 
and enzyme expression compared to that of human skin equivalents generated in the absence of 
cytokines. These changes were similar to those observed in atopic eczema skin, indicating that 
inflammation in AE skin affects lipid biosynthesis. This study demonstrates the importance of chain 
length alterations for the impaired skin barrier function in AE and that inflammation may play an 
important role in the altered lipid biosynthesis in atopic eczema patients.    
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The interaction between bicyclic monoterpene diol and neuropeptides on keratinocyte cell 
proliferation and apoptosis
N Weiler, C Ding, K Brar, SA Glick and W Lee Dermatology, SUNY Downstate, Brooklyn, NY
Neuropeptides play a role in inflammation and exhibit their effects on the skin, which can manifest 
via various skin diseases such as atopic dermatitis and delayed hypersensitivity reactions. We have 
shown that bicyclic monoterpene diol (BMTd) has a modulatory effect on the production of nitric 
oxide and inflammatory cytokines. Previous studies demonstrated that calcitonin gene-related pep-
tide (CGRP) can enhance keratinocyte cell proliferation by modulating the cell cycle; decreasing 
G1/G0 and increasing S and G2/M phases. In this study, we were interested in characterizing the 
effects of BMTd and CGRP on cell proliferation and apoptosis. Immortalized keratinocytes (hTERT, 
KCs) were treated with CGRP and BMTd alone and in combination; apoptosis and cell quantity 
were analyzed by flow cytometry following Annexin V-FITC/Propidium iodide staining and by 
MTT assay, respectively. Western blot analyses were performed looking at NFkB expression, and 
expression of caspase proteins involved in apoptotic death. FACS analyses showed that CGRP 
significantly decreases cell apoptosis by 6-fold (P <0.05). Similarly, BMTd-treated KCs demon-
strated a dose-dependent effect on apoptosis (32-fold and 17-fold decrease when treated with 
BMTd at 3mM and 9mM, respectively). Compared to untreated KCs, treatment with CGRP and 
BMTd in combination (CGRP+BMTd) showed a significant increase in apoptosis (P<0.001). MTT 
results indicated enhanced cell proliferation by CGRP and increased cytotoxicity by BMTd and 
CGRP+BMTd. Western blot analyses suggest that BMTd modulates levels of NK-1, NF-kB p105, 
and caspase proteins. Our findings suggest the interaction between CGRP and BMTd plays a role 
in cell proliferation, and apoptosis possibly via the NF-kB signaling pathway, suggesting a potential 
therapeutic target to modulate inflammatory processes.    
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Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum
AT Slominski1, 2, T Kim,1 W Li,3 AE Postlethwaite4 and RC Tuckey5 1 Pathology, UTHSC, 
Memphis, TN, 2 Dermatology, UAB, Birmingham, AL, 3 Pharmaceutical Sciences, UTHSC, 
Memphis, TN, 4 Medicine, UTHSC, Memphis, TN and 5 School of Chemistry and 
Biochemistry, UWA, Crawley, WA, Australia
Previously we identified novel pathways of vitamin D3 (D3) and 7-dehydrocholesterol (7DHC, pro-
vitamin D3) metabolism in vitro that are initiated by CYP11A1 and modified by other CYP enzymes. 
The major metabolites display anti-proliferative, prodifferentiation and anti-inflammatory activities, 
while being non-toxic and non-calcemic at relatively high doses. To investigate these pathways 
in vivo, we extracted human epidermis from samples obtained from 13 individuals including 6 
African-Americans (AA) and 7 Caucasians (C), and sera from 12 individuals (91% Caucasians) and 
analyzed them by LC/qTOF-MS alongside corresponding standards. Epidermal and serum samples 
showed the presence of D3 hydroxy-derivatives corresponding to 20(OH)D3, 22(OH)D3, 25(OH)
D3, 1,25(OH)2D3, 20,22(OH)2D3, 20,23(OH)2D3, 20,24(OH)2D3, 20,25(OH)2D3, 20,26(OH)2D3 
and 17,20,23(OH)3D3, plus 1,20(OH)2D3 which was detectable only in the epidermis. Levels of 
25(OH)D3 and 20(OH)D3 showed respective values of 0.42±0.14 and 1.97±0.72 ng/mg protein 
for the epidermis and 33.58±5.36 and 3.29±0.91 ng/ml for serum. 22(OH)D3 was detected in 
serum at a concentration of 6.31±1.75 ng/ml The stratification of the epidermal hydroxy D3 values 
according to race, age and gender showed no significant differences except that there were higher 
levels of 25(OH)D3 in AA vs C (p<0.05). In serum, higher levels of both 20(OH)D3 and 25(OH)
D3 were found in older vs younger individuals and females had higher levels of 22(OH)D3. We 
also detected products of 7DHC metabolism by CYP11A1 in the epidermis and serum including 
22(OH)7DHC, 20,22(OH)27DHC and 7-dehydropregnenolone. The above hydroxy-secosteroids 
and Δ7-steroids were also detected in the pig adrenal gland, a tissue expressing high CYP11A1 
activity. Thus, we have detected novel CYP11A1-derive secosteroids in the skin and serum and 
suggest that they act as hormones in vivo.    
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Histamine impairs keratinocyte barrier function
A De Benedetto, T Yoshida, S Fridy, JS Park and LA Beck Dermatology, University of 
Rochester Medical Center, Rochester, NY
Histamine is an aminergic neurotransmitter involved in physiologic and pathologic processes such 
as pruritus, inflammation and vascular leak. Recent evidence suggests that histamine inhibits the 
terminal differentiation of keratinocytes. This coupled with the increased histamine release observed 
in the skin of patients with Atopic Dermatitis (AD) raises the question that histamine may play 
a role in AD barrier impairment. In this study, we investigated the effect of histamine on tight 
junction (TJ) function and composition in primary human keratinocytes (PHK) undergoing Ca2+-in-
duced differentiation. TJ integrity was assessed by trans-epithelial electrical resistance (TEER) and 
paracellular fluorescein flux. We used specific histamine receptor antagonists H1R (Cetirizine, 10 
μM), H2R (Cimetidine, 100 μM), or H4R (JNJ7777120, 10 μM) to examine their contribution to 
histamine-mediated effects on TJ. Additionally, the expression of the Histamine Receptors (H1R 
and H4R) and TJ components was analyzed in our in vitro model. With histamine treatment we 
observed a reduction of TEER (10 and 100 μM, P<0.001, n=10) and enhancement of permeability 
(100 μM, P<0.001, n=9). Antagonists of H1R and H4R, but not H2R, blocked histamine-mediated 
TEER reduction. We detected greater expression of H1R and H4R mRNA as PHK differentiate with no 
effect of histamine exposure on HR expression (P≤0.05, n=5). Histamine reduced mRNA expression 
of filaggrin and the TJ molecule, claudin1. Interestingly, H1R was reduced in both lesional and 
nonlesional AD skin (P<0.01). In conclusion, these results suggest that histamine may contribute to 
the epidermal barrier defects and treatment with H1R and H4R antagonists may improve epidermal 
barrier function in subjects with AD.    
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Epidermal SIRT1 loss disrupts skin barrier integrity and sensitizes mice to epicutaneous 
allergen challenge
M Ming,1 B Zhao,1 CR Shea,1 S Palak,1 L Qiang,1 SR White,2 D Sims1 and Y He1 1 University 
of Chicago, Chicago, IL and 2 Department of Medicine, Section of Pulmonary / Critical Care, 
University of Chicago, Chicago, IL
Skin barrier integrity requires a highly coordinated molecular system involving the structural protein 
filaggrin. Mutational loss of the skin barrier protein filaggrin predisposes individuals to the develop-
ment of atopic dermatitis (AD). Here we show that filaggrin is regulated by the protein deacetylase 
SIRT1, and that SIRT1 is critical for skin barrier integrity. Epidermal-specific SIRT1 ablation causes 
AD-like skin lesions in mice, and mice with epidermal SIRT1 deletion are sensitive to percutaneous 
challenge by the protein allergen ovalbumin. In both normal human keratinocytes and mouse skin, 
SIRT1 knockdown or genetic deletion down-regulates filaggrin, and regulation of filaggrin expression 
by SIRT1 requires the deacetylase activity of SIRT1. SIRT1 also promotes the activation of the aryl 
hydrocarbon receptor (AhR), and the AhR ligand restores filaggrin expression in SIRT1-inhibited 
cells. As compared with normal human skin, SIRT1 is down-regulated in the lesions of atopic 
dermatitis as well as non-atopic dermatitis. Our findings demonstrate a critical role of SIRT1 in 
skin barrier maintenance, open up new opportunities to use SIRT1 as a pharmacological target, 
and may facilitate the development of mechanism-based agents for AD prevention and therapy.   
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An optimized inexpensive emollient mixture improves barrier repair in murine skin
M Man,1 G Man,1 C Cheung,1 D Crumrine,1 M Hupe,1 Z Hill2 and PM Elias1 1 Dermatology, 
VA Med Ctr/UCSF, San Francisco, CA and 2 Population Health Sciences, Institute for Global 
Health/Univ College, London, United Kingdom
Maintenance of epidermal permeability barrier homeostasis is certainly the most crucial of cutane-
ous functions, because it allows life in a terrestrial environment. Defective epidermal permeability 
barrier results not only in excessive water loss, but also induction of cutaneous inflammation and 
an increased risk of infections, which together contribute to increased mortality in premature and 
low birth weight infants. Hence, improvement of permeability barrier function by topical therapies 
could become a valuable approach to reduce neonatal mortality rates; to prevent/treat dermatoses 
accompanied by barrier abnormalities; and to prevent microbial pathogen colonization/invasion. 
Yet, effective barrier-enhancing formulations that are also affordable to economically-challenged 
populations are not yet available. In the present study, we optimized the ratio of several inexpensive 
ingredients, previously shown to be individually effective for restoring barrier homeostasis, and 
then assessed the efficacy and the mechanisms of action of this mixture in normal murine skin. 
Our results show that pretreatment of murine skin with this optimized mixture accelerates barrier 
recovery, although basal barrier function, skin surface pH and stratum corneum hydration remained 
unchanged. The barrier-enhancing effects and potent antimicrobial activities of this optimized 
mixture could be attributed at least in part to a parallel stimulation of epidermal differentiation and 
antimicrobial peptide expression. Since the individual ingredients in this mixture are inexpensive, 
this optimized mixture could be widely deployed for treating neonates in developing (Third World’) 
countries and could be widely used for preventing skin disorders associated with epidermal per-
meability barrier abnormalities.    
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X-ray crystal structure of the keratin 1–keratin 10 heterodimer reveals a molecular basis for 
associated keratinopathies
CG Bunick Dermatology, Yale University, New Haven, CT
To satisfy a knowledge gap in correlating epidermal protein structure with molecular function in 
the skin, the x-ray crystal structure of the heterodimer between the 2B segments of keratin 1 and 
keratin 10 was determined at 3.3 Å resolution. Keratins 1 and 10 are the main proteins forming 
intermediate filaments in suprabasal keratinocytes, where their role is multifactorial: cytoskeletal 
support, intracellular signaling, and scaffolding for protein interactions. All keratins share a basic 
structural organization, with four helical or coiled-coil segments (denoted 1A, 1B, 2A, 2B) flanked 
by N- and C-terminal glycine-rich sequences. The keratin 1–keratin 10 crystal structure demonstrates 
an intimate association of the coiled-coil segments, with a predominantly hydrophobic intermolec-
ular interface. The molecular surface of the structure shows three prominent acidic residues at the 
N-terminal end of the 2B coiled-coil, surrounded by residues of basic charge. The distal portion of 
the molecule is acidic. Several surface-exposed hydrophobic residues exist. Keratin 1 and keratin 
10 mutations known to cause a patient phenotype in epidermolytic ichthyosis, cyclic ichthyosis 
with epidermolytic hyperkeratosis, and palmoplantar keratosis (epidermolytic and non-epidermo-
lytic) were mapped onto the structure and demonstrated a C-terminal mutation hotspot with sur-
face-exposed and intramolecular mutations. This is the first atomic resolution crystal structure of a 
suprabasal keratin intermediate filament protein complex, and it has similarities/differences from 
the structure previously described for the keratin 5/14 2B dimer. The C-terminal mutation hotspot 
suggests the 2B coiled-coil is critical for keratin 1–keratin 10 function in suprabasal keratinocytes, 
possibly for promotion of intermediate filament assembly.    
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Filaggrin mutations do not associate with Staphylococcus aureus skin colonization in Euro-
pean American atopic dermatitis subjects
T Yoshida,1 N Rafael,2 D Babineau,3 K Artis,3 A Lockhart,3 G David,3 M Boguniewicz,4 
P Ong,8 A De Benedetto,1 J Hanifin,7 EL Simpson,7 AS Paller,5 E Guttman-Yassky,6 
L Schneider,9 R Mathias,2 K Barnes,2 D Leung4 and LA Beck1 1 University of Rochester, 
Rochester, NY, 2 Johns Hopkins, Baltimore, MD, 3 Rho, Inc., Chapel Hill, NC, 4 National 
Jewish Health, Denver, CO, 5 Northwestern University, Chicago, IL, 6 Mt. Sinai, New York, 
NY, 7 OHSU, Portland, OR, 8 CHLA, Los Angeles, CA and 9 Boston Children’s Hospital, 
Boston, MA
Filaggrin (FLG) mutations are strongly linked to atopic dermatitis (AD) and several subphenotypes. 
Whether FLG mutations are a risk factor for Staphylococcus aureus (S. aureus) colonization has 
not been established. FLG deficient individuals may be at risk because of their increased skin 
pH and reduced FLG breakdown products that have anti-staphylococcal properties. The Atopic 
Dermatitis Research Network (ADRN) has found that 42% of AD subjects are colonized and 24% 
have a history of S. aureus skin infections. Genotyping of the 5 most common FLG null mutations 
(2282del4, R501X, R2447X, 3702delG, S3247X) was performed in European American (EA) 195 
colonized (ADStaph+) and 260 non-colonized (ADStaph-) subjects. Colonized subjects (ADStaph+) 
grew S. aureus from skin swabs obtained at lesional or nonlesional sites and noncolonized subjects 
(ADStaph-) had no growth. Clinical disease severity was assessed by Rajka/Langeland score, allergen 
sensitization by total serum IgE level and a history of S. aureus skin infections was captured as a 
Yes/No response. FLG carrier status was 27.5% in EA AD subjects. Logistic regression adjusted for 
disease severity, allergen sensitization, age and gender showed no association between individual, 
total number of FLG mutations, or FLG carrier status with the ADStaph+ subphenotype (P=0.053-
0.819, 0.436, 0.564, respectively). The 5 common FLG null alleles do not affect EA AD subjects 
susceptibility to skin colonization. Additional analysis is underway in ethnically diverse populations.   
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Nanotopography facilitates in vivo transdermal delivery of high molecular weight therapeutics 
through an integrin-dependent mechanism
L Walsh,2 J Ryu,1 S Bock,3 M Koval,4 T Mauro,1 R Ross5 and T Desai2 1 Dermatology, 
University of California-San Francisco, San Francisco, CA, 2 Bioengineering and Therapeutic 
Sciences, University of California-San Francisco, San Francisco, CA, 3 Bioengineering, 
Georgia Institute of Technology, Atlanta, GA, 4 Emory University, Atlanta, GA and 5 Kimberly 
Clark Corporation, Atlanta, GA
The purpose of this study was to develop a drug delivery technology that can reversibly increase 
the skin’s permeability to permit transdermal delivery of high molecular weight therapeutics such 
as biologics. To accomplish this, we coated silica microneedles with nanotopography, which has 
been shown to significantly enhance high molecular weight paracellular transport in vitro, and we 
tested these devices both in animals and in cultured epithelial cells, We demonstrate that nanoto-
pography applied to microneedles significantly enhances transdermal delivery of etanercept, a 150 
kDalton (kDa) therapeutic, in both rats and rabbits. We further show that this effect is mediated 
by remodeling of the tight junction (TJ) proteins claudin and occludin, which in turn increase 
paracellular permeability between epithelial cells. These structural changes in TJs are initiated via 
integrin binding to the nanotopography, followed by phosphorylation of myosin light chain (MLC) 
and activation of the actomyosin complex. This proof-of-concept study introduces a drug delivery 
platform that could be further developed and leveraged to permit transdermal passage of biologic 
therapeutics, which play an increasingly important role both within and outside of dermatology   
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Tight junction barrier dysfunction induced by epidermis-specific claudin-1 ablation is suffi-
cient to cause dermatitis in mice
A Kubo,1 T Hirano1, 2, M Yokouchi,1 H Kawasaki,1 T Atsugi1, 3 and M Amagai1 1 Keio Univ, 
Tokyo, Japan, 2 Maruho Co., Kyoto, Japan and 3 KOSE Co., Tokyo, Japan
The stratum corneum (SC) and tight junctions (TJs) form physical barriers in the skin. Impairment 
of the SC and/or TJ barriers has been reported in atopic dermatitis skin, however, the direct con-
sequence of TJ barrier dysfunction on dermatitis onset is unknown. In this study, we established 
tamoxifen (TAM)-inducible epidermis-specific claudin-1–knockout mice (K14-creERT+/-, Cldn1flox/
flox mice) and investigated the pathophysiology of primary epidermal TJ defects in adult mice. By 
in vivo permeation assay, TJ leakage was initially observed focally on day 4 after TAM injection, 
and had developed fully on day 8. The TJ dysfunction was size dependent; the TJs became leaky 
to small (<0.5 kDa tracers) but not large (>30 kDa tracers) molecules. By contrast, the elevation of 
transepidermal water loss (TEWL) commenced later, on day 10, and reached its peak by day 18. 
The dermatitis phenotype, including erythema with scales, also became apparent on day 18. Water 
evaporation through the isolated SC sheets was normal on day 8 but significantly increased on day 
18. Therefore, SC barrier impairment and TEWL elevation were secondarily induced after TJ leakage 
in this mouse model, and mice showed TJ barrier dysfunction alone without SC barrier impairment 
between days 4 and 8. Interestingly, scratching behaviors developed on day 4 at the time of TJ 
leakage and persisted thereafter. Furthermore, most Langerhans cells in the ear skin became activated 
by day 8, even when scratching was prohibited by neck collar. These findings indicate that TJ barrier 
dysfunction alone is sufficient to trigger the onset of dermatitis, and this mouse model provides an 
important tool to elucidate the mechanism underlying the itch caused by skin barrier dysfunction.   
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X-ray crystallographic analysis of the human profilaggrin N-terminus provides a mechanism 
for binding of interacting proteins
CG Bunick1 and R Presland2, 3 1 Dermatology, Yale University, New Haven, CT, 2 Oral 
Health Sciences, University of Washington, Seattle, WA and 3 Medicine (Division of 
Dermatology), University of Washington, Seattle, WA
The 2.2 Å resolution structure of the N-terminal S100 fused-type calcium binding domain of human 
profilaggrin bound to calcium ions was determined using x-ray crystallography. The molecular 
surface of profilaggrin contains a concave pocket located between four α-helices. Since the pocket 
is formed by a distinct composition of amino acids, there are unique biochemical properties of the 
profilaggrin pocket compared to other S100 and calcium-binding proteins; notably, the pocket is ~ 
47% hydrophobic, 33% polar, 14% basic, and 6% acidic. The molecular features of the hydrophobic 
pocket suggest a putative role for its involvement in protein-protein interactions. A combination of 
immunoprecipitation, mass spectrometry, and yeast-two-hybrid approaches were used to identify 
three proteins that bind the N-terminus of profilaggrin: annexin II/p36, stratifin/14-3-3 sigma, and 
Hsp27. Stratifin was shown to co-localize with profilaggrin in the differentiating granular cell layer of 
human skin. The structural and biochemical data suggest a model where the profilaggrin N-terminus 
uses calcium-dependent and calcium-independent protein interactions to regulate its involvement 
in terminal epidermal differentiation.    
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Stratifin implication in UVB stress response and dermal remodeling
A Lebleu, G Oberto, Y Ferreira, C Gondran, K Cucumel and N Domloge Ashland Specialty 
Ingredient, Sophia Antipolis, France
Stratifin, also called 14-3-3 σ protein, is a member of the 14-3-3 protein family involved in several 
intracellular functions such as signal transduction pathways, cellular trafficking, cell differentia-
tion, cell survival and protein folding. Stratifin is expressed in differentiated keratinocytes of the 
suprabasal layers of the epidermis, with a progressive increase in the spinous and granular layers. 
This protein promotes extra-cellular matrix (ECM) turnover and tissue remodeling by modulating 
MMP-1 expression at the dermal level. With aging, the epidermal-dermal cross-talk diminishes and 
the communication between skin compartments is less effective. In addition, skin is chronically 
exposed to UV radiation that could influence the epidermal-dermal cross-talk. In the present work, 
we studied the implication of stratifin in keratinocyte response to UVB exposure in vitro. Moreover, 
based on our previous results showing the ability of a peptide to modulate stratifin, we selected a 
hydrolyzed soya extract that could fulfill this condition. Our results showed increases in both stratifin 
and hyaluronic acid synthesis, on ex vivo skin biopsies treated with this extract. Moreover, the con-
ditioned medium of NHK treated with the extract induced a moderate increase in MMP-1 expression 
associated with an increase in collagen neosynthesis in cultured fibroblasts. In addition, the results 
obtained on keratinocytes in vitro exposed to UVB highlighted the implication of stratifin in UVB 
stress response. To evaluate the effect of the extract on the visible signs of aging, an in vivo study 
was conducted on 14 volunteers for a eight-week period. At the end of the treatment and compared 
to placebo, a significant decrease of the of wrinkles parameters was observed. In conclusion, the 
optimization of epidermal-dermal cross-talk through stratifin modulation appears as a key target to 
induce a message of dermal remodeling and could be beneficial to thwart the visible signs of age.   
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Reconstructed skin models with modulated expression of miR-203, a key microRNA in the 
epidermal differentiation, allowing the in vitro study of the predicted consequences, based 
on a bioinformatic network model of the differentiation process
C Serre, C Capallere, C Plaza, L Bergeron, N Esselin, V Busuttil, J Botto and N Domloge 
Ashland Specialty Ingredients, Sophia Antipolis, France
During the entire lifespan, the epidermis undergoes a continuous renewal through proliferation 
and differentiation of keratinocytes anchored within the dermo-epidermal junction. This multistep 
process requires a complex and coordinated program of gene expression and inhibition. Using 
tissue engineering, epidermis can be reconstructed in vitro, starting from cultured normal keratino-
cytes, thus providing a valuable study model. Recent findings suggest that microRNAs, a category 
of non-coding RNAs (ncRNAs) which are post-transcriptional regulators of gene expression, play 
an essential role in the epidermis renewal, particularly by controlling the shift between basal 
proliferation of keratinocytes and suprabasal differentiation. Interestingly, some long non-coding 
RNAs which belong to another category of ncRNAs with diverse activities also participate in the 
structuration of the epidermis. Bioinformatics is a powerful approach allowing the modelization 
of the complex interactions between protein coding genes, microRNAs and LncRNAs. With the 
help of this bioinformatics tool, we established an interaction network representing keratinocyte 
differentiation, in order to modelize the interactions between more than 300 key players in this 
process. In the epidermis, microRNA-203 (miR-203) is a master regulator of the exit from stem-
ness by controlling DNp63 expression, and other genes. With the aim of establishing examples 
of reconstructed epidermal test models to study the role of particular microRNAs on epidermal 
differentiation, we down-regulated miR-203 expression or, on the contrary, we increased content 
in miR-203 in human keratinocytes, and studied the effects of each type of modulation in cultured 
cells, and after 3D epidermal reconstruction.    
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Specific culture medium to improve keratinocytes proliferation and 3D epidermis 
reconstruction
C Capallere, C Plaza, M Arcioni, I Garcia, E Bauza, J Botto and N Domloge Ashland Specialty 
Ingredient, Sophia Antipolis, France
Methods to isolate and cultivate human primary keratinocytes were published 40 years ago (Rhe-
inwald and Green, 1975). Many approaches use an irradiated fibroblast feeder layer to initiate 
adhesion and growth of keratinocytes. Our keratinocyte extraction approach and the specificity 
of our medium reduces the need for both a feeder layer and fetal calf serum, while permitting a 
high extraction rate of proliferative keratinocytes. After several days of culture, cells grow in clus-
ters, compared to other extraction approaches where cells grow individually, suggesting a more 
undifferentiated state. The subsequent reconstruction of 3D epidermises with the same medium 
supplemented in Ca2+ and specific growth factors can produce a well differentiated epidermis after 
17 days of culture at the air/liquid interface. Several quality controls are performed to ensure the 
conformity of reconstructed epidermises in terms of viability (MTT assay), barrier integrity (ET50 test) 
and morphological appearance (H&E stain). Commercial models of reconstructed epidermis already 
exist and are validated by the European Union Reference Laboratory for alternatives to animal testing 
(EURL ECVAM) and serve as a reference for cutaneous irritation test (OECD TG 439). Aiming at 
validating the model we developed, we performed an irritation test following OECD guidelines, and 
tested 20 referenced chemicals (irritant and non irritant compounds, solid or liquid) applied topically 
during 42 minutes with 42 hours of post incubation (protocol 42 bis) on three different batches of 
reconstructed epidermis. To be validated, measured parameters must be equal or be greater than 
the indicated value: specificity (70%), sensitivity (80%) and accuracy (75%). Parameters measured 
on the model we developed were similar or better than these specifications, with a specificity of 
70%, a sensitivity of 100% and an accuracy of 85%. Ashland proprietary epidermis model is in 
the process to be submitted to EURL ECVAM for their validation so that the model can be used as 
a reference for cutaneous irritation test.    
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Expression of long non-coding RNAs in the skin: Study in cultured human cells and recon-
structed skin tissue
J Botto, C Serre, C Plaza, L Bergeron, V Busuttil, C Capallere and N Domloge Ashland 
Specialty Ingredients, Sophia Antipolis, France
A large part of the genome (98%), once called “junk” DNA, in fact encodes many non-protein 
coding RNAs (ncRNAs) that are today considered as important regulators of the major cellular and 
physiological processes. Over the past few years, thanks to the advances in genomics analyses, 
emerging new regulators of skin physiology with various modes of action were reported as part of 
the ncRNAs, particularly the microRNAs and the long non-coding RNAs (lncRNAs). Almost 2,000 
microRNAs have been identified in humans, and most of them act as gene expression negative 
regulators, by repressing transcription and translation. Concerning lncRNAs, if more than 2,600 
have been described in human to date, only 173 transcripts are known with published evidence 
(Hugo Gene Nomenclature Committee, http://www.genenames.org/rna/LNCRNA), suggesting that 
a myriad of new activities and modes of action are to be unveiled. In the skin, only a few lncRNAs 
are today known to exert a physiological role, e.g., DANCR (differentiation antagonizing non-protein 
coding RNA), PRINS (psoriasis associated non-protein coding RNA induced by stress), and TINCR 
(tissue differentiation-inducing non-protein coding RNA) in the epidermis; BANCR (BRAF-activated 
non-protein coding RNA) and SPRY4-IT1 (SPRY4 intronic transcript 1) in melanocytes; and HOTAIR 
(HOX transcript antisense RNA) and HOTTIP (HOXA distal transcript antisense RNA) in fibroblasts. 
In this study, we characterized the expression of various lncRNAs in several cultured human skin 
cell types and in 3D- reconstructed epidermis, and focused on studying the role of TINCR and 
DANCR in the regulation of the epidermal homeostasis.    
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Impact of environmental particulate pollution on skin: effect of PM10-like particles applied 
on human skin cultured cells and on 3D reconstructed epidermis, and study of miRNAs 
expression
V Busuttil, L Bergeron, C Serre, C Plaza, N Esselin, E Bauza, C Capallere, J Botto and 
N Domloge Ashland Specialty Ingredients, Sophia Antipolis, France
The skin is exposed on a daily basis to UV radiation and environmental pollution such as volatile 
organic compounds, cigarette smoke, ozone, and particulate matter (PM). Major effects on human 
skin have been linked with air pollution, and more particularly with PM. Indeed, repetitive and 
prolonged exposure to environmental particulate pollution acts synergistically with UV exposure to 
exert negative consequences on skin, with probable epigenetic impacts. This potentially can lead 
to increased visible photodamage and skin aging, allergic and inflammatory conditions, and even 
skin cancers. Particulate air pollution is triggered by particles from the nanometer to the micrometer 
range, which contain harmful compounds such as heavy metals and polycyclic aromatic hydro-
carbons that may modulate skin xenosensory pathways (e.g. arylhydrocarbon receptor signaling 
pathway - AhR). A bioinformatics model taking into account AhR, phase I / phase II metabolism 
enzymes and focusing on the skin antioxidant response, was designed in order to modelize the 
relationships between key genes and microRNAs involved or dysregulated as a consequence to skin 
exposure to PM. With the goal of studying the bioinformatics predictions allowed by the model, 
we exposed cultured human skin keratinocytes and 3D reconstructed skin models to standardized 
particulate fine dust up to 10 μm in diameter (PM10-like). Then, we observed the subsequent mor-
phological modifications, cellular viability, protein markers using specific immunodetection, DNA 
damage and measured the expression level of specific genes and microRNAs. In conclusion, the 
complementary approach involving bioinformatics and experimental testing on skin engineered 
tissue constitutes a strong platform for understanding and characterizing in vitro the effects of PM 
exposure, and represents an important implementation for the identification of protective strategies.   
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Endocannabinoid modulators influence skin barrier repair, inflammation, proliferation and 
differentiation in mouse irritant contact dermatitis
E Proksch,1 M Soeberdt,2 C Neumann1 and C Abels2 1 Dermatology, University of Kiel, Kiel, 
Germany and 2 Dr. August Wolff GmbH & Co. KG Arzneimittel, Bielefeld, Germany
Endocannabinoids are derivatives of arachidonic acid and important regulators of cell signalling. 
Cannabinoid receptors are involved in keratinocyte proliferation and differentiation; elevation of 
the endogenous cannabinoid tone leads to strong anti-inflammatory effects. Here we explored 
the influence of two endocannabinoid modulators, a selective fatty acid amide hydrolase (FAAH) 
inhibitor WOBE440 (WO440) and WOL067-531 (WO531), a selective inhibitor of endocannabinoid 
reuptake, compared to hydrocortisone(17-)butyrate (HC-B), on skin permeability barrier repair, epi-
dermal proliferation, differentiation, antimicrobial protein expression and inflammation in hairless 
mice. Barrier disruption and skin irritation were induced by tape-stripping or by SDS patch test. 
Immediately after barrier disruption 30 μl of a solution of WO440, WO531 (0.5%), and HC-B (0.1%) 
or the vehicle were applied topically. Barrier repair monitored by TEWL was significant delayed 
at 1.5, 3, 5, and 7 hours by WO531 (0.5%) and HC-B. Immuno-histology at 24 h showed that the 
tape-stripping induced increase in epidermal proliferation and thickness as well as the expression of 
the differentiation marker keratin 6 (CK6), mouse beta-defensins mBD-3 and mBD-14 were reduced 
by topical applications of WO440, WO531 and HC-B. Expression of involucrin and loricrin was 
slightly reduced, whereas filaggrin expression was slightly increased by the endocannabinoids. Also, 
the SDS irritation induced increase in total inflammatory cells, CD3 cells and IL-1β were reduced 
by WO531 and WO440. In summary, we showed that topical application of WO531 and HC-B 
after experimental skin barrier disruption and irritation resulted in a transient delay in skin barrier 
repair, reduction of epidermal hyperproliferation, epidermal thickness, CK-6 and mBD-3/mBD-14 
expression and inflammation. Endocannabinoid modulator WO531 might be useful to control 
inflammation, proliferation and differentiation in contact dermatitis.    
360
Nitric oxide differentially regulates epidermal proliferation in normal and inflamed skin
M Man, G Man, C Cheung, M Hupe and PM Elias Dermatology, UCSF/VA Medical Ctr, San 
Francisco, CA
Previous studies have demonstrated that nitric oxide accelerates wound healing, while inhibition of 
nitric oxide synthase prevents epidermal hyperproliferation, induced by repeated barrier disruption. 
Together, these results suggest that nitric oxide plays a critical role in epidermal homeostasis. In the 
present study, we assessed the role of nitric oxide in epidermal proliferation in normal vs. barrier-per-
turbed or inflamed murine models. Our results show that while topical applications of the nitric 
oxide donor (S-nitroso-N-acetylpenicillamine, SNAP) did not alter epidermal proliferation in normal 
murine skin, topical applications of SNAP enhanced epidermal proliferation in mice with a disrupted 
barrier. Conversely, topical nitric oxide scavenger (2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimid-
azoline-1-oxyl-3-oxide, carboxy-PTIO) inhibited epidermal proliferation after repeated barrier 
disruption. Moreover, topical SNAP inhibited epidermal proliferation, while topical carboxy-PTIO 
increased epidermal proliferation in an atopic dermatitis model, induced by repeated hapten (oxaz-
olone) applications. Finally, barrier disruption induced epidermal hyperproliferation in both normal 
and inducible nitric oxide synthase knockout mice; while in contrast, barrier disruption did not 
stimulate epidermal proliferation in neural nitric oxide synthase knockout mice. Taken together, 
these results indicate that nitric oxide differentially regulates epidermal proliferation in normal and 
inflamed skin, and further suggest that neural nitric oxide synthase could play an important role in 
regulating epidermal proliferation.    
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Mitochondria move along keratin 14, with potential implications for epidermolysis bullosa 
simplex pathogenesis
A Suto,1 R Abe,1 T Koshiba,2 Y Fujioka,3 Y Ohba3 and H Shimizu1 1 Dermatology, Hokkaido 
University Graduate School of Medicine, Sapporo, Japan, 2 Biology, Kyushu University, 
Fukuoka, Japan and 3 Cell Physiology, Hokkaido University Graduate School of Medicine, 
Sapporo, Japan
Mitochondrial movement and distribution are regulated by actin and microtubules, which serve 
as tracks for their directed movement at sites where their functions are required. However, it has 
been unclear whether mitochondria contact with and move along keratins. To evaluate the potential 
regulation of mitochondria and keratin, we examined mitochondria and keratin 5/14 (K5/14) in 
human keratinocytes. The mitochondria were found to co-localize with K5 and K14. In immuno-
precipitation assays, mitofusin 2, an outer mitochondrial membrane protein, was found to connect 
mitochondria with K5/14. Time-lapse imaging showed that the mitochondria moved along K14. 
These data indicate that mitochondria use K14 for traffic and positioning in the cytoplasm. The 
absence or mutation of keratin 8 or 18 causes a predisposition to liver injury in humans. In mice, 
the absence of keratin 8 was reported to induce abnormal mitochondrial function in hepatocytes, 
suggesting that keratin mutation might contribute to liver disease via interaction with mitochondria. 
In addition, abnormal mitochondrial distribution has been reported in epidermolysis bullosa simplex 
(EBS), a type of epidermolysis bullosa that is caused by a mutation in KRT5 or KRT14. Therefore, 
we addressed the reason for the abnormal mitochondrial distribution in EBS. We generated HaCaT 
cells with mutant KRT14 harboring p.Arg125Cys, the most common mutation in Dowling-Meara 
type of EBS. The KRT14 mutation caused keratin clumping and abnormal mitochondrial distribution 
in the cytoplasm. Furthermore, mitochondrial motility was found to be defective, especially around 
keratin aggregations. These data suggest that keratin clumping disturbs normal mitochondrial motil-
ity, causing unsuitable mitochondrial positioning and dysfunction. We propose that mitochondrial 
dysfunction possibly leads to the cytolysis of basal cells, which is a crucial pathogenetic event in EBS.   
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Sustained transdermal delivery of methotrexate using novel in situ forming hydrogel 
microneedles
A Sivaraman and AK Banga Pharmaceutical Sciences, Mercer University, Atlanta, GA
This is a first study to evaluate if sustained drug delivery can be achieved through novel in situ 
hydrogel microneedles formed in epidermis. The principle in this technique is based upon the 
transition property of the thermosensitive polymer from solution at room temperature to gel at skin 
temperature (32°C). Methotrexate (MTX), as oral or injection dosage forms, has been widely used 
to treat solid tumors but its toxicity with increased dosing is a major limitation. The high hydro-
philicity (log P: -1.85) limits its use in passive transdermal drug delivery. This study investigated two 
formulations; one with 20.0%w/v non-ionic triblock amphiphilic thermosensitive copolymer and 
another without the thermosensitive polymer but with water at two different MTX concentrations 
0.2%w/w and 0.4%w/w. Using maltose microneedles with a length of 500μm stacked in three 
rows, dermatomed human skin was microporated for two minutes followed by dose of 100μL of 
the prepared formulations. The MTX permeation through skin was conducted for 72 hours using the 
Franz diffusion cell in pH 7.4 phosphate buffer as the receptor solution maintained at 37°C. This 
resulted in a cumulative delivery of 3.89±0.60 μg/sq.cm and 10.27±6.98 μg/sq.cm from hydrogel 
microneedles and 25.30±12.69 μg/sq.cm and 27.63±7.04 μg/sq.cm from formulations without the 
thermosensitive polymer for 0.2%w/w and 0.4%w/w MTX respectively. Statistically, MTX delivery 
of the formulations with and without thermosensitive polymer were significantly different from each 
other. The formulations without the thermosensitive polymer ceased MTX delivery at around 48 
hours but a steady and sustained delivery was observed for hydrogel microneedles even beyond 
72 hours. After application of thermosensitive polymer formulation, the formulation flowed into 
the microporated sites on the skin and transitioned from solution to gel, forming in situ hydrogel 
microneedles where MTX was continuously delivered. This confirms that sustained transdermal 
drug delivery is achievable at low drug concentrations using these novel in situ forming hydrogel 
microneedles.    
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Analysis of extracellular-matrix and cell-adhesion genes modulated by mechanical massage 
applied in combination with a cosmetic emulsion
BB Swinka,1 CM de Carvalho,1 A Weihermann,1 DC Schuck,1 N Boldrini,2 VV da Silva,1 
MT Costa,1 AH Ribeiro,3 A Fujita,3 CA Brohem1 and M Lorencini1 1 Grupo Boticario, Sao 
Jose dos Pinhais, Brazil, 2 Universidade Positivo, Curitiba, Brazil and 3 University of Sao 
Paulo, Sao Paulo, Brazil
Massage therapies are associated with pathological improvements, and have also been extensively 
used for esthetic purposes. This study aimed to evaluate part of the molecular mechanisms involved 
in massage by investigating modulation of gene expression associated with cell adhesion and the 
ECM (extracellular matrix) induced by esthetic massage combined with a cosmetic emulsion. Thir-
teen female volunteers clinically characterized as having grade II or III cellulite were recruited and 
were subjected to skin biopsies in the gluteofemoral region before and after treatment. Each volun-
teer’s leg was considered an experimental unit to reduce individual variability. The study population 
was divided into: (1) legs treated with a cosmetic emulsion and (2) legs treated with a cosmetic 
emulsion and massage. Examination of 84 genes analyzed by qPCR revealed a predominance of 
up-regulation in individuals treated with the emulsion and massage in comparison to individuals 
treated only with the emulsion (fold change > 1.5, and p < 0.05). The main genes modulated 
were: ECM proteases (ADAMTS8, MMP1, MMP3, MMP9 and MMP11), transmembrane molecules 
(HAS1, ITGAL), adhesion molecules (COL8A1 and LAMA1) and cell-matrix adhesion molecules 
(ADAMTS13). Concluding, the combination (cosmetic emulsion and massage) is therefore recom-
mended to increase the effectiveness of a product and obtain the desired benefits in the treatment 
of skin disorders such as cellulite. The lack of scientific data on this technique can very often lead 
to skepticism among health professionals and even patients or consumers of cosmetic treatments. 
This study helps to elucidate some of the molecular phenomena associated with this therapy.   
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A novel inhibitor of plasmin and urokinase suppresses inflammation in keratinocytes in-vitro
R Campiche,1 S Doppler,1 D Imfeld,1 P Lais,1 P Wikstroem,1 AV Rawlings2 and R Voegeli1 
1 Personal Care, DSM Nutritional Products, Kaiseraugst, Switzerland and 2 AVR Consulting 
Ltd, Northwich, United Kingdom
Plasmin and urokinase (plasminogen activator), two serine proteases, participate in many physi-
ological and pathological reactions in skin, e.g. plasmin activates matrix-metalloprotease (MMP) 
precursors leading to the degradation of key structural proteins in skin. Moreover, plasmin and 
urokinase are not only linked to inflammatory skin disorders with barrier impairment like atopic 
dermatitis, psoriasis and rosacea but are also up-regulated in milder forms of barrier disruption 
such as dry skin conditions. In addition, we recently reported that increased transepidermal water 
loss, indicative for impaired stratum corneum (SC) barrier function, significantly correlated with 
up-regulation of their activities in the SC implying that their inhibition would be beneficial to skin. 
The aim of the current study was to elucidate the pathways that are involved by inhibition of these 
proteases. A novel specific inhibitor based on the dipeptide structure benzylsulfonyl-D-Ser-homo-
Phe-(4-amidino-benzylamide) has a Ki value for plasmin of 46 nM and for urokinase of 25 nM. In 
an in-vitro inflammation model using primary human keratinocytes stimulated with IL-1beta and 
TNFalpha, 100μM of the inhibitor suppressed the activity of plasmin by 41% (p<0.05) and uroki-
nase by 97% (p<0.001). Furthermore, the inhibitor down regulated the inflammatory chemokines 
IL-8 by 54% (p<0.05) and CXCL5 by 67% (p<0.01). Moreover, it suppressed the expression of 
MMP-9 by 69% (p<0.01), which confirmed a link between plasmin and MMP-9 activation. Plasmin 
and urokinase are not only up regulated in inflammatory skin disorders, but their levels are also 
increased in non-observable sub-clinical micro-inflammatory or pre-inflammatory skin conditions. 
Clearly, their inhibition would be beneficial to skin. Our results demonstrate that a novel specific 
inhibitor of plasmin and urokinase represents a new approach targeting cutaneous inflammatory 
skin conditions with barrier impairment.    
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Regulation and disruption of the site-specific skin gene KRT9 
D Kim, M Hossain, A Nieves, L Gu, N Yang, S Oh, S Han, J Qi, JM Taube, S Kang and 
LA Garza Dermatology, Johns Hopkins School of Medicine, Baltimore, MD
Despite similar components, the heterogeneity of skin characteristics across the human body is 
enormous. It is classically believed that site-specific fibroblasts in the dermis control post-natal 
skin identity by modulating the behavior of the surface-overlying keratinocytes in the epidermis. 
To begin testing this hypothesis, we characterized the gene expression differences between volar 
(ventral; palmo-plantar) and non-volar (dorsal) human skin. We show that KERATIN 9 (KRT9) is the 
most uniquely enriched transcript in volar skin (P<0.05, N=3), consistent with its etiology in genetic 
diseases of the palms and soles. Additionally, ectopic KRT9 expression is selectively activated in 
vitro by volar fibroblasts (P<0.01, N=4). However, high KRT9 expression robustly occurs in the 
absence of all fibroblasts (P<0.05, N=6). We demonstrate that the mechanism is through overlapping 
paracrine or autocrine β-catenin signaling in each respective context. For example, although Wnt5a 
was the wnt most enriched in volar fibroblasts (P<0.05, N=3), and has been shown to induce KRT9, 
it significantly increases in non-volar keratinocytes alone as they express KRT9 (P<0.05, N=3). To 
functionally test our hypothesis, gain of function β-catenin activation promotes KRT9 expression 
(P<0.01, N=3); loss of function β-catenin with either knockdown or DKK-1 treatment, decreases 
KRT9 in both autocrine and paracrine contexts (P<0.02, N=3). Finally, in our search for in vivo 
examples of ectopic expression of KRT9 independent of volar fibroblasts we found that in the human 
skin disease Lichen Simplex Chronicus (LSC), KRT9 is robustly activated outside of volar sites. 
Combined with clinical features like hypopigmentation in some individuals, ours results suggest 
LSC is a phenocopy for volar skin. These results highlight the complexities of site-specific gene 
expression and its disruption in skin disease.    
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Loss of loricrin results in impaired incorporation of fillagrin into cornified cell envelopes
Y Ishitsuka,1 N Box,1 RH Rice2 and DR Roop1 1 Department of Dermatology Charles C. Gates 
Center for Regenerative Medicine and Stem Cell Biology, University of Colorado Anschutz 
Medical Campus, Aurora, CO and 2 Environmental Toxicology, University of California, 
Davis, CA
Cornified cell envelopes (CEs) consist of a macromolecular assembly of highly insoluble proteins 
that are covalently cross-linked by Nε (γ-glutamyl)-lysine isopeptide bonds and play a key role in 
maintaining the integrity of the stratum corneum (SC). Although loricrin (LOR) is a major compo-
nent of CEs and CEs and SC of loricrin knockout mice (LKO) are susceptible to mechanical stress, 
unchallenged LKO mice appear to be normal. To gain further insight into the apparent lack of a 
phenotype in LKO mice, we performed mass spectrometric analysis on LKO CEs. Surprisingly, we 
discovered that the levels of filaggrin (FLG) were greatly reduced in the SDS-insoluble epidermal 
protein fraction isolated from LKO mice compared to wild type. In contrast, we found that the levels 
of FLG in the SDS-soluble epidermal protein extract were actually higher in LKO mice compared 
to wild type as determined by immunoblotting. Taken together, the results suggest the impaired 
isopeptide cross-linking of FLG into LKO CEs. Consistent with the decreased levels of FLG in LKO 
CEs, we showed that LKO mice exhibit an increased UVB susceptibility as demonstrated by the 
increased positive staining for p53 and γ-H2AX in a UVB dose-dependent manner. Similar to FLG 
knockout mice, LKO mice showed an increased production of OVA-specific serum IgE following the 
topical application of OVA, as well as an enhanced local inflammatory reaction. Considering the 
fact that lysine is not found within the mouse FLG repeat sequence, LOR appears to be necessary 
for the incorporation of the FLG monomer into CEs by way of providing lysine residues for the 
cross-linking of FLG via glutamine residues. Taken together, these results suggest that the increased 
susceptibility of LKO mice to UVB and epicutaneous challenge with allergens may be due in large 
part to the marked reduction of FLG in LKO CEs.    
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The LXR ligand VTP-38543 represents a new class of therapeutic agents for the treatment 
of atopic dermatitis
Y Zhao,1 S Meng,1 PB Noto,1 KK Lipinski,1 YE Bukhtiyarov,1 L Zhuang,2 C Tice,2 W Zhao,2 
C Dong,2 S Lotesta,2 A Marcus,2 K Leftheris,4 Y Zheng,3 K Fan,3 SB Singh,3 D Claremon,2 
GM McGeehan1 and D Lala1 1 Biology, Vitae Pharmaceuticals, Fort Washington, PA, 2 
Chemistry, Vitae Pharmaceuticals, Fort Washington, PA, 3 Computational Chemistry, Vitae 
Pharmaceuticals, Fort Washington, PA and 4 Chemistry, Cellgene, San Diego, CA
Atopic dermatitis (AD) is a common skin disease that affects children and adults with lifetime 
prevalence rates of ~20%. While the pathophysiology of AD is multifaceted, it includes skin barrier 
dysfunction and inflammation. Thus, therapies that repair epidermal barrier function and reduce 
inflammation would offer a novel class of therapeutic agents for AD. The epidermis functions as 
a permeability barrier of lipid-enriched lamellar membranes primarily comprised of fatty acids, 
cholesterol and ceramides. Liver X Receptors (LXRs), LXRα and LXRβ, are members of the nuclear 
receptor family that act as key regulators of epidermal lipid synthesis and metabolism. Ligand-me-
diated activation of LXRs leads to keratinocyte differentiation, induction of key genes involved in 
lipid synthesis and cholesterol transport, and improved barrier function in animal models. LXR 
activation also exerts anti-inflammatory effects in vitro and in mouse models of dermatitis. Here, we 
describe the characterization of VTP-38543, a potent (Ki=26 nM) LXRβ agonist that is >10x selective 
vs LXRα and >1000x against other nuclear receptors. In human keratinocytes VTP-38543 induces 
genes critical for normal lamellar body formation and lipid synthesis such as ABCG1 and SREBP1c. 
VTP-38543 also inhibits production of the pro-inflammatory cytokine IL-6 in human macrophages 
at the RNA and protein level. When applied topically to mice as a cream formulation, VTP-38543 
induced ABCG1 and SREBP1c gene expression in skin tissue. Topical application of VTP-38543 
also dose-dependently attenuated inflammation and reduced ear weight and thickness in a mouse 
model of TPA-induced dermatitis. Thus, VTP-38543 represents a new class of small molecules that 
offers therapeutic potential for the treatment of AD via a novel mechanism.    
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Epidermis-specific mesotrypsin is involved in corneocyte desquamation and is regulated by 
an intrinsic inhibitor, serpin B12
M Masashi,1 H Yamanishi,1 Y Matsumoto,1 M Yamamoto1, 2, Y Hachiya,1 R Tsuboi2 and 
T Hibino1 1 Shiseido, Yokohama, Japan and 2 Dermatology, Tokyo Medical University, 
Tokyo, Japan
It is suggested that kallikrein-related peptidases (KLKs) are key players in corneocyte desquama-
tion and this process is regulated by lympho-epithelial Kazal-type inhibitor (LEKTI). However, it 
is unclear how these proteases are activated and how activated KLKs are released from LEKTI in 
the upper cornified layer. Previously we reported cloning of a new mesotrypsin gene product, 
keratinocyte-specific mesotrypsin from the cDNA library. We hypothesized that mesotrypsin is 
involved in the desquamation process. We found that mesotrypsin effectively activated pro-KLK5 
and pro-KLK7. Although LEKTI domains D2-7, D8-9 and D10-15, which were major products in 
corneocyte extracts, strongly inhibited KLK5 and KLK7, mesotrypsin was not inhibited by any LEKTI 
domains but rather degraded them. Proximity Ligation Assay indicated that mesotrypsin was present 
closely enough with KLKs and was interacting with KLKs. It has been reported that mesotrypsin 
is insusceptible to intrinsic inhibitors. Surprisingly, we isolated novel inhibitor and identified it as 
SERPINB12. Lineweaver-Burk plots indicated that SERPINB12 inhibited mesotrypsin with mixed-
type and non-competitive manner (Ki=8.95×10-6mM), while KLK5 was inhibited with competitive 
manner (Ki=2.98×10-5 mM). We examined age-related changes of SERPIN B12 activity in corneocyte 
extracts obtained from the forearm skin of 20s, 40s and 60s. Relatively low mesotrypsin-inhibitory 
activity was observed in the young age group (20s), while those of 40s and 60s showed marked 
up-regulation of mesotrypsin-inhibitory activity. Collectively, our work suggested that mesotrypsin 
is a key player in corneocyte desquamation and SERPIN B12 regulates it in the upstream of this 
cascade. Increase of SERPIN B12 in the aged group would be related to the thickened cornified 
layer in the aged skin. Our findings provided a new insight into the desquamation mechanisms, in 
which mesotrypsin and SERPIN B12 play critical roles.    
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A natural cosmetic active ingredient dedicated to the needs of pregnant woman’s skin
S Bredif, S Leclere-Bienfait and C Baudouin Laboratoires Expanscience, Epernon, France
During pregnancy, the skin, mainly affected by the particular hormonal status, is submitted to 
important physiological modifications. Indeed, pregnant women’s skin is frequently described as 
suffering from itch and dryness and being more irritable and sensitive. In addition, the skin has to 
withstand important variations in volume and stretchings. That’s why a cosmetic active ingredient 
(avocado peptides) has been specifically developed in order to address the needs of pregnant wom-
en’s skin. This patented ingredient is obtained from avocado cake, according to a biotechnological 
process, in compliance with our sustainable policy. We have demonstrated the biological activity 
of avocado peptides using in vitro and ex vivo models: Avocado peptides were able to significantly 
inhibit the release of histamine (-21%, p<0.01) and tryptase (-30%, p<0.01) by mast cells that were 
stimulated with calcium ionophore or substance P. In keratinocytes, the production of hyaluronic 
acid, evaluated by ELISA, and glycosaminoglycans, evaluated by measuring the incorporation of 
35S-sulfate, were significantly enhanced by 31% (p<0.05) and 34% (p<0.05), respectively. Further-
more, fluorescent immunostaining of human skin explants showed that avocado peptides clearly 
enhanced the expression of hyaluronic acid (by +220%) and strongly restored the expression of 
filaggrin and transglutaminase after barrier disruption. Finally, avocado peptides were able to sig-
nificantly increase collagen I (+44%, p<0.01) and elastin (+78%, p<0.01) gene expression levels 
in fibroblasts, assessed by real-time RT-PCR. Based on our expertise in skin physiology and plant 
extraction we developed a natural active ingredient able to preserve the comfort and beauty of the 
skin in the hormonal environment of motherhood: avocado peptides with soothing, moisturizing 
and restructuring properties.    
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Expression of a novel immunoglobulin protein in the skin and other epithelia
H Mitchell and TC Wikramanayake Department of Dermatology & Cutaneous Surgery, 
University of Miami Miller School of Medicine, Miami, FL
Mpzl3, or Myelin protein zero-like 3, is a small immunoglobulin (Ig) protein with a single Ig-like 
domain. Mpzl3 is a key regulator of hepatic lipogenesis and whole-body energy expenditure. Addi-
tionally, it has critical functions in the skin. Deletion of exons encoding the Ig domain (Mpzl3 -/-), or 
a spontaneous missense mutation in a critical amino acid residue in the Ig domain, resulted in the 
loss of Mpzl3 function. In previous studies, we have shown that loss of function in Mpzl3 resulted 
in severe skin and hair abnormalities. Within 2 weeks after birth, Mpzl3 -/- mice showed unkempt 
and greasy hair coat, and hair loss soon after. Mpzl3 -/- skin showed severe sebaceous gland 
hypertrophy and increased dermal thickness sometimes accompanied by epidermal hyperplasia. 
In addition, Mpzl3 -/- mice frequently developed dermatitis phenotype with dandruff-like flaking. 
To better understand Mpzl3 function in the skin, in this study, we investigated Mpzl3 promoter 
activity during epidermal development and the hair cycle, using a knocked-in lacZ reporter gene 
(encoding beta-Gal) driven by the endogenous Mpzl3 promoter. We detected beta-Gal activity in 
all the skin samples after embryonic day 17, and higher beta-Gal activity during the hair follicle 
growth phase (anagen) than the regression or resting phase. Beta-Gal activity was detected in the 
exterior layers of the epidermis, sebaceous gland, and the companion layer and the inner root 
sheath of the anagen hair follicles, but was not detected in the outer root sheath. In addition, we 
also detected beta-Gal activity in other stratified epithelia, including the oral mucosa, the tongue, 
and the esophagus. Our results suggest that Mpzl3 plays an important role in the development of 
the skin, and likely other stratified epithelia.    
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NuMA/microtubule interactions are critical for asymmetric cell divisions and epidermal 
morphogenesis
L Seldin and T Lechler Cell Biology, Duke University, Durham, NC
The epidermis is a multilayered epithelium that uses asymmetric divisions of basal progenitors to 
drive stratification during embryogenesis. The conserved protein NuMA plays a key role in estab-
lishing proper spindle orientation, though the underlying mechanism remains poorly understood. 
In addition to its known role in recruiting the molecular motor dynein, we find that direct interac-
tions between NuMA and microtubules (MTs) are also critical for spindle orientation in cultured 
keratinocytes. We reveal that NuMA can specifically interact with MT ends and remains attached 
to depolymerizing MTs. To test the role of NuMA/MT interactions in vivo, we generated mice with 
an epidermal-specific in-frame deletion of the NuMA MT-binding domain. This deletion caused 
randomization of spindle orientation in vivo, resulting in defective epidermal differentiation and 
barrier formation, as well as neonatal lethality. Conditional deletion of the NuMA MT-binding 
domain in adult mice resulted in severe hair growth defects, identifying an essential role for spindle 
orientation in hair morphogenesis. We found that NuMA was required in hair follicle matrix cells 
and that differentiation of matrix-derived progeny was disrupted when NuMA was mutated. Based 
on these data, we propose a novel mechanism for force generation during spindle positioning and 
demonstrate that spindle orientation is used reiteratively in multiple distinct cell populations during 
epidermal morphogenesis.    
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Biomarkers of skin health and barrier efficiency
N Raj,1 N Parisi,1 AV Rawlings,1 R Voegeli,2 ME Lane,1 M Munday1 and S Gibbons1 1 School 
of Pharmacy, University College London, London, United Kingdom and 2 DSM Nutritional 
Products Ltd., Wurmisweg, Switzerland
The aim of this study was to compare stratum corneum (SC) barrier properties for the cheek, leg 
and forearm (FA) of healthy volunteers of different ethnicities and to correlate these properties with 
cysteine protease (bleomycin hydrolase (BH), calpain-1 (C-1) and serine protease (plasmin (PL)) 
activities. We are interested in these enzymes as the measures of barrier integrity (PL) and late 
stage filaggrinolysis (BH, C-1). Twelve healthy volunteers (4 Caucasian, 4 Black, 4 Asian subjects) 
were recruited with formal written consent. Sixteen subsequent tapes were removed from the leg 
and forearm and eight from the cheek. Transepidermal water loss (TEWL) was measured before 
and after every 4th tape stripping. Amounts of SC protein removed on tapes were quantified using 
infrared densitometry. Tapes 4-6 were pooled to measure the activity of BH, C-1 and PL. High TEWL 
values were recorded for the cheek compared with leg (p=0.002) and FA (p=0.002) and cheek SC 
protein removed was low compared with leg (p=0.000) and forearm (p=0.002). Surprisingly the 
TEWL values were higher in males compared with females for cheek (p=0.04). Protease activity 
values were higher for the cheek (p=0.04) compared with forearm FA and leg. Higher activities of 
BH (p=0.02) and PL (p=0.02) were noted for cheeks in males. No differences were observed for 
ethnic groups in any parameter. These findings suggest that cheek SC may be considered as a less 
competent barrier than other skin sites, considering the lower amount of SC protein removed, higher 
enzyme activities and higher TEWL. We believe that the activity of PL can be directly related to 
the UV exposure, which amplifies the extracellular proteolysis thereby weakening the barrier. This 
is consistent with the higher TEWL values obtained for male participants. The weaker barrier may 
signal a positive feedback mechanism to produce more natural moisturising factor by up-regulating 
BH and C-1 activities.    
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SCARA3 is required for topically delivered spherical oligonucleotide nanoconjugates to pen-
etrate the epidermal barrier
Q Song,1 W Briley,2 S Narayan,2 X Wang,1 C Mirkin2 and AS Paller1 1 Dermatology, 
Northwestern university, Chicago, IL and 2 Chemistry, Northwestern University, Evanston, IL
Class A scavenger receptors (SR-As) clear pathogens, transport lipid, and mediate uptake of polyan-
ionic ligands in macrophages. Spherical nucleic acids (SNAs) are highly anionic oligonucleotide 
nanoconjugates, spherically arrayed around a gold or liposomal nanoparticle. SNAs in simple 
moisturizer can penetrate mouse skin, human 3-D skin equivalents and human abdominoplasty 
skin to knock down epidermal targets. We previously found that: i) SR-A inhibitors (fucoidan 
and polyI) prevent SNA uptake in NHEKs; ii) epidermis expresses SR-As, predominantly SCARA3 
and to a lesser extent MARCO (SCARA2); and iii) expression is differentiation-specific (MARCO 
in suprabasal and SCARA3 primarily in basal epidermis). We now hypothesized that SR-As are 
critical for the remarkable traversal by SNAs of the epidermal barrier. Incubation of 3-D cultures 
and abdominoplasty explants at 4oC ablated SNA penetration, confirming that active endocytosis 
is required. Incubation of 3-D rafts with SR-A inhibitor polyI reduced SNA penetration by 80%, 
confirming a role for one or more SR-A. To determine the role of MARCO vs. SCARA3 in penetra-
tion and cell uptake, NHEKs were transduced with lentiviral shRNA constructs targeting MARCO, 
SCARA3, or both SR-As. Using flow cytometry, uptake of Cy5-labelled SNAs in monolayer NHEKs 
was reduced by 57% with the combination, 48% with SCARA3 shRNA, and 29% with MARCO 
shRNA, as compared with vehicle or vector controls. Transduced NHEKs in 12 d fully-differentiated 
3-D skin equivalents showed a 70-75% decrease in MARCO mRNA expression with MARCO or 
both shRNAs and a 75% decrease in SCARA3 with either SCARA3 or both shRNAs; no nonspecific 
knockdown was seen. Despite the suprabasal localization of MARCO, depletion of MARCO did 
not reduce Cy5-labelled SNA penetration. In contrast, penetration was diminished by 87% with 
SCARA3 knockdown, suggesting that specific recognition of SNAs by SCARA3 is critical for the 
traversal of SNAs through the epidermal barrier.    
374
Nuclear IL-33 is involved in cell proliferation via formation of contractile ring in normal 
human epidermal keratinocytes
H Tsuda,1 M Komine1, 2, S Tominaga2 and M Ohtsuki1 1 Dermatology, Jichi Medical 
University, Shimotsuke-shi, Japan and 2 Biochemistry, Jichi Medical University, Shimotsuke-
shi, Japan
IL-33, a member of IL-1 superfamily, behaves as a cytokine that acts in the maturation of Th2, and 
is involved in the pathogenesis of inflammatory diseases, such as asthma and atopic dermatitis. Our 
previous report showed that IL-33 also worked as a nuclear protein, inhibiting NFκB function. How-
ever, nuclear function of IL-33 is still unclear. To clarify the function of nuclear IL-33 on keratinocyte, 
we investigated viability and proliferation of normal human epidermal keratinocytes (NHEKs) with 
or without knockdown (KD) of IL-33 expression. We designed siRNA, which effectively knocked 
down IL-33 expression, and transfected them into NHEKs, and investigated cell proliferation. IL-33 
KD cells had lower cell proliferation and distinct cell morphology compared to control cells. MTT 
assay revealed that proliferation of IL-33 KD cells was significantly decreased at 24hr after siRNA 
transfection, however it was recovered after 48hr. IL-33 KD cells showed significantly decreased 
BrdU uptake continuously for 48hrs. We analyzed cell cycle by flow cytometry, and found that 
the number of cells in G2/M phase was increased in IL-33 KD cells compared to that of control 
cells. Immunofluorescence study revealed that there were many binucleated cells in IL33 KD cell 
culture, which were scarcely found in control cells. F-actin staining revealed that contractile ring 
was not formed in binucleated IL-33 KD cells. Western blot analysis revealed that IL-33 KD cells 
showed attenuated myosin phosphorylation, which was reported to associate with contractile ring 
formation. Reduced expression of Ect2 was observed, which would have caused reduced activation 
of RhoA, which could result in reduced myosin phosphorylation. Our results suggest that nuclear 
IL-33 is positively involved in cell proliferation through promoting contractile ring formation by 
positively regulating myosin phosphorylation, expression of Ect2, and activation of RhoA in NHEKs.   
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Involvement of the aryl hydrocarbon receptor (AhR) in the murine skin barrier function
K Haas,1 S Grether-Beck,1 W Bloch,2 J Krutmann1 and C Esser1 1 IUF, Düsseldorf, Germany 
and 2 Deutsche Sporthochschule, Köln, Germany
The aryl hydrocarbon receptor (AhR) is a transcription factor involved in adaptive xenobiotic 
response. AhR is activated by certain small chemicals, including the tryptophan dimer FICZ gen-
erated by UVB irradiation. Emerging evidence supports physiological functions of AhR in cell 
development and immune responses. AhR is expressed at high levels in the barrier organs of skin 
and gut. We previously showed that AhR is expressed highly in keratinocytes (KC), Langerhans cells 
(LC), γδ-T cells, fibroblasts, and melanocytes and affects their functions. Regarding the skin barrier, 
evidence shows that AhR-ligands can accelerate keratinocyte differentiation and increase filaggrin 
expression. Here, we used different AhR-deficient mouse models to investigate the possible role of 
AhR in preserving the skin barrier. First, we measured the kinetics of transepidermal water (TEWL) 
loss after tape stripping. In young AhR-deficient (AhRKO) mice TEWL increased significantly faster, 
remained at significantly higher levels, and returned to the baseline more slowly than in wildtype 
littermate controls (WT). This effect was lost in old mice (>9 months) due to an equally increased 
TEWL in the old WT, indicating a premature aging phenotype of AhRKO. There was a significant 
difference in TEWL kinetics between WT mice and keratinocyte, but not LC conditional AhRKO 
mice, indicating that KC AhR expression is important for skin barrier function. In agreement with 
the TEWL data, the expression of several tight/gap junction genes such as occludin, E-cadherin, 
connexin 43 and desmoglein3 increased upon tape stripping only weakly in young AhRKO com-
pared to WT. In line with this occludin and E-cadherin have AhR-responsive elements in their 
promoters. Moreover, electron microscopy suggested that the cell-cell contact between KC is less 
tight in AhRKO compared to WT indicating a disturbed basal membrane. Our results suggest that 
AhR expression is critical for skin barrier integrity and that AhR represents a molecular target for 
the development of novel therapeutic approaches for skin barrier diseases.    
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Interpretation of dermatological drug penetration and drug effects using multiple imaging 
tools
G Hamm, R Legouffe, D Bonnel, A Heron, F Pamelard and J Stauber ImaBiotech, Lille, France
The better understanding of drug penetration, kinetics and effects (efficacy or toxicity) in the vari-
ous skin layers (epidermis, dermis and deep dermis) is a key in the drug development process for 
pharmaceutical, dermatological products. To address these issues, MultimagingTM is used as a 
new advanced label free technique based on the combination of mass spectrometry imaging and 
histology. It provides useful and precise information about exogenous compounds’ targeting in the 
skin substructures (at the micrometer scale), their amount, their impact on endogenous molecules 
(metabolites, lipids, peptides or proteins) and their potential adverse effects (inflammatory or toxicity 
response). Human skin explants were used to study several drugs’ effects. For each drug, administra-
tion, doses and time points were chosen based on their respective pharmacokinetics data. Several 
fresh sections were prepared and analyzed by H&E staining to identify skin substructures in tissue 
sections. Then, high resolution mass spectrometry imaging was used to identify molecular distribu-
tion of drugs, metabolites and biomarkers within tissue sections. We introduce a new concept with 
a combination of imaging techniques to study drugs’ bio-distribution and to assess their efficacy or 
toxicity within skin sections. We show a differential penetration of exogenous compounds through 
the skin layers depending on their molecular properties. We provide a global lipid profile for each 
skin substructure (ceramides, sphingomyelin …) to evaluate their changes after drug administration. 
Moreover, accumulation of specific biomarkers such as the eicosanoids was discovered in specific 
inflammatory areas. These biomarkers were identified and structural information was provided. We 
describe the usefulness of MultimagingTM to understand in vivo pharmacology of drug candidates 
which is essential to pharmaceutical development. The correlation between skin substructures or 
disease-related alterations and molecular species’ localization provides important information about 
skin biology or skin disease mechanism taking place within tissue.    
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Expression of Orai3 correlates with aging-related changes in stress-induced calcium signaling 
in keratinocytes
S Denda1, 2, J Kumamoto2, 3, K Takei2, 3, M Goto1, 2, M Nagayama3, 2 and M Denda1, 2 1 
Shiseido Research Center, Yokohama, Japan, 2 Japan Science and Technology Agency, 
Tokyo, Japan and 3 Research Institute for Electronic Science, Hokkaido University, Sapporo, 
Japan
Various morphological and physiological changes appear in human epidermis with aging: stratum 
corneum becomes dry and flaky, the epidermal permeability barrier becomes fragile, and the 
recovery rate after barrier disruption becomes slower. In young, healthy epidermis, calcium ion 
concentration is higher in the uppermost layer of the epidermis, but this calcium gradient dissipates 
with aging. In our recently developed mathematical model of epidermal calcium dynamics, calcium 
channels and pumps play crucial roles. Thus, we hypothesized that the aging-associated change 
of calcium dynamics in keratinocytes might be due to altered expression of calcium ion modula-
tors. When we observed the recovery process from hydraulic stress-induced intracellular calcium 
elevation in epidermal keratinocytes from a wide age range of subjects, we found that recovery 
tended to be delayed in keratinocytes from older subjects. We next evaluated mRNA expression of 
calcium pumps and channels, and found that the mRNA level of Orai3 was significantly correlated 
with donor age and inversely correlated with recovery rate of intracellular Ca2+ concentration. 
The recovery rate of cells from aged subjects was accelerated by knockdown of Orai3. Moreover, 
Orai3 expression was higher in differentiated keratinocytes than in proliferative cells. Based on these 
results, we propose that Orai3 expression in keratinocytes changes with aging and that the resulting 
changes of Ca2+ balance or dynamics could be related to senile skin symptoms.    
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SVEP1 plays a crucial role in normal epidermal function
L Samuelov,2 Q Li,1 R Bochner,2 N Najor,3 J Koetsier,3 N Malchin,2 T Goldsmith,2 M Grafi-
Cohen,2 D Vodo,2 G Fainberg,2 E Warshauer,2 T Rogers,2 A Ishida-Yamamoto,4 N Erez,2 
I Goldberg,2 A Irvine,5 L Shultz,6 K Green,3 J Uitto,1 E Sprecher2 and O Sarig2 1 Thomas 
Jefferson University, Philadelphia, PA, 2 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3 
Northwestern University, Chicago, IL, 4 Asahikawa Medical University, Asahikawa, Japan, 5 
Trinity College, Dublin, Ireland and 6 Jackson Laboratory, Bar Harbor, ME
SVEP1 is a recently identified multi-domain cell adhesion protein, orthologous to the mouse poly-
dom protein, which has been shown to mediate cell-cell adhesion in an integrin-dependent man-
ner in osteogenic cells. In the present study, we characterized SVEP1 function in the epidermis. 
SVEP1 was found by qRT-PCR to be ubiquitously expressed in human tissues, including the skin. 
Confocal microscopy revealed that SVEP1 is normally expressed in the cytoplasm and nucleus of 
basal and suprabasal epidermal cells. siRNA-mediated down-regulation of SVEP1 expression in 
primary keratinocytes (KCs) resulted in decreased expression of major epidermal differentiation 
markers. Similarly, SVEP1 down-regulation was associated with disturbed differentiation and marked 
epidermal acanthosis in three-dimensional skin equivalents. Homozygous Svep1 knockout mice 
were embryonic lethal. Therefore, to assess the importance of SVEP1 for normal skin homeostasis 
in vivo, we down regulated SVEP1 in zebra fish embryos with an Svep1-specific splice morpholino. 
Scanning electron microscopy revealed a rugged epidermis with perturbed microridge formation in 
the center of the KCs in morphant larvae which died at 6-7 dpf. Transmission electron microscopy 
analysis demonstrated abnormal epidermal cell-cell adhesion with gaps and disadhesion between 
cells in Svep1-deficient morphant larvae. In summary, our results indicate that SVEP1 plays a critical 
role during epidermal ontogenesis and differentiation.    
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T-cell independent role for Langerhans cells in the epidermal stress-response
J Lewis, JF Gibson and M Girardi Dermatology, Yale School of Medicine, New Haven, CT
Langerhans cells (LC) comprise a dendritic network within the suprabasilar epidermis. We have 
previously suggested that LC may function as key players in the epithelial-stress response, where 
they coordinate with resident γδ T cells and αβ natural killer T (NKT) cells to alter the local immune 
milieu. In addition, we have recently discovered that LC promote UVB-induced p53 mutant kera-
tinocyte clonal expansion and provoke tumor outgrowth. LC were also associated with marked 
enhancement of UVB-induced epidermal expression of IL-22, independently of resident or infiltrat-
ing αβ or γδ T cells, suggesting that LC may also play a more general role in supporting keratinocyte 
proliferation as part of the epidermal stress-response. Consistent with this hypothesis, at 5 weeks of 
UVB-exposure (a time with minimal difference in the numbers and size of p53 clonal KC islands 
between TCRβ-/-δ-/-.NLC (LC-intact) and TCRβ-/-δ-/-.DTA (LC-deficient) epidermis, we were able 
to detect a greater epidermal thickness in association with the presence of LC. Removal of the 
stratum corneum and superficial KCs by repetitive tapestripping resulted in a greater transepidermal 
waterloss (TEWL) in LC-inact versus LC-deficient epidermis. A more aggressive disruption of the 
epidermis by repetitive razor abrasion resulted in an even greater TEWL in LC-intact epidermis that 
also showed histologic evidence of epidermal hyperplasia and hyperkeratosis. Furthermore, a single 
application of TPA to the ears provoked a greater ear swelling response in LC-intact skin, while 
twice weekly application of TPA ultimately showed enhanced epidermal hyperplasia in association 
with the presence of LC. These data are consistent with LC serving as fundamental contributors to 
the epidermal stress-response via stimulation of keratinocyte proliferation and dedifferentiation, 
independently of the presence of αβ and γδ T cells and regardless of the mode of epidermal damage 
(e.g. ultraviolet radiation, physical disruption, chemical irritant).    
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Improvement of Lox expression in epidermis by Cichorium intybus
C Reymermier, V Degrave, J Saget, S Grenier, M Chavan and V Andre-Frei BASF Beauty Care 
Solutions, Lyon, France
In previous studies, we evidenced that LOX is strongly decreasedwith ageing in skin. Now we 
demonstrate that LOX contributes to the regulation of keratinocytes differentiation and the con-
trol of the good cell architecture in epidermis. To demonstrate LOX expression in epidermis, we 
developed a specific model of kinetic culture on keratinocyte monolayers to follow that both LOX 
mRNA and protein expression were increased during keratinocytes differentiation. We showed 
then that LOX increased after initiation of the keratinocyte differentiation. Given these results, we 
performed on keratinocyte monolayers a proteomic screening in order to identify a plant extract 
(Cichorium intybus) as a lead candidate to reactive LOX expression. Consequently, we were looking 
for benefits on this reactivation on the epidermal differentiation process in our skin equivalent model 
MIMESKIN® by observing by immunohistochemistry Ki67, transglutaminase, and desmocollin-1. In 
addition, we showed with two methods (DELPHIA quantification and immunohistochemistry) that 
0.5 % of Cichorium intybus extract increased collagen 1 (COL1) fibers synthesis by 22% (p<0.05) in 
fibroblast monolayers. In addition it also improved by 172% the collagen fibers deposition in aged 
fibroblast monolayers. Next, in order to prove the global in vivo effects of the plant extract on both 
dermis and epidermis we have done a clinical trial on 62 Caucasians healthy human volunteers 
applying a cream containing 2% CIE or 0.07% of retinol after twice or single daily application for 
2 months. We showed that Cichorium intybus extract at 2% has improved significantly by 25% 
(p<0.05) the appearance of wrinkle depth, decreased significantly visible pores by 25% (p<0.001), 
improved elasticity of the skin by 19% (p<0.001) and has shown an as good as retinol effect after 
56 days of treatment.    
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Tight junction response to impaired lipid barrier
A Celli, R Sun, K Park, B Goubran, Y Uchida, PM Elias, K Feingold and T Mauro Dermatology, 
VA Medical Center, University of California San Francisco, San Francisco, CA
The post-natal epidermis, largely through its lipid barrier, blocks transepidermal water loss and ion 
diffusion. Previous studies have shown that normal tight junction (TJ) organization and expression is 
required for embryonic and peri-natal development of a competent lipid barrier, that the TJ barrier 
appears to recede as the lipid barrier is formed during normal prenatal development, and that TJ 
protein levels are upregulated in response to acute or physical lipid barrier abrogation. In this report, 
we show that TJ barrier function does not relax, but is retained if normal air-exposed lipid barrier 
development is blocked by inhibiting normal lipid synthesis or processing. We find that the tight 
junctions respond to impaired lipid barrier development by decreasing tight junction permeability, 
as assessed by lanthanum permeation, resistance (R) or short-circuit current (Isc) measurements using 
an Ussing chamber. In contrast to physical barrier perturbation, impairing lipid barrier development 
does not increase TJ protein levels. These findings demonstrate that TJ function may be upregulated 
without increasing TJ protein levels and suggest that the TJ barrier can sense and respond to defects 
in lipid barrier development.    
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Desmocollin ectodomain shedding and cantharidin acantholysis 
N Li, M Park, Z Liu and LA Diaz Dermatology, University of North Carolina at Chapel Hill, 
Chapel Hill, NC
Cantharidin, a toxin secreted by many species of blister beetle, induces acantholysis (loss of kera-
tinocyte cohesion) and blister formation in human skin. The mechanism of cantharidin-induced 
acantholysis, resembling pemphigus acantholysis, remains unclear. In this study we investigated the 
effects of cantharidin on desmosomal cadherins in normal human epidermal keratinocyte cultures. 
Our results show that following cantharidin treatment the ectodomain of desmocollin 2/3 (Dsc2/3) is 
shed to the culture medium in a time- and dose-dependent manner. Cantharidin-induced release of 
the soluble Dsc2/3 (80 kDa) is blocked by metalloprotease inhibitors GM6001 and TAPI-0, demon-
strating that Dsc2/3 ectodomain is proteolytically cleaved from the cell surface by metalloproteases. 
In addition to shedding of the ectodomain, Dsc2/3 is also proteolytically cleaved intracellularly, 
producing an 85 kDa-fragment. The 85 kDa cleavage product is blocked by proteasome inhibitor 
MG132 and cysterine protease inhibitor E64d, but not by serine protease inhibitor AEBSF or caspase 
inhibitor Boc-D-FMK. Interestingly, both the ectodomain shedding and the intracellular cleavage 
of Dsc2/3 are blocked by genistine, a tyrosine kinase inhibitor. This result suggests that tyrosine 
kinase is required for cantharidin action and activation of tyrosine kinase is upstream of proteolytical 
processing of Dsc2/3. To the best of our knowledge, this is the first demonstration of desmocollin 
ectodomain shedding. Taken together, our data demonstrate that desmocollin is targeted by cantha-
ridin, and desmocollin shedding and cleavage may contribute to cantharidin-induced acantholysis.   
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The role of TGF-β signaling-mediated miR-486-3p on the inhibition of keratin 17 in the 
pathogenesis of psoriasis
M Jiang,1 Z Sun,2 L Gao1 and G Wang1 1 Department of Dermatology, Xijing Hospital, 
Fourth Military Medical University, Xi’an, China and 2 Xinjiang Urumuqi 23rd Hospital of 
PLA, Urumuqi, China
Psoriasis is characterized by hyperproliferation of keratinocyte with an aberrant kertain expres-
sion pattern. Keratin 17(K17), a type I keratin absent from normal epidermis, is highly expressed 
in psoriatic lesions. Downregulation of K17is usually correlated with the remission of psoriasis, 
thus it is of great clinical significance to reveal the underlying mechanism of K17 regulation. In 
this study we used bioinformatics assays to predict microRNAs that may affect K17 expression 
and identifed miR-486-3p as a candidator. MiR-486-3p was then found declined significantly in 
psoriatic epidermis compared with normal epidermis by qRT-PCR. Keratinocytes transfected with 
miR-486-3p mimics exhibited significantly downregulation of K17 compared with negative controls. 
A dual-luciferase reporter assay showed that the expression level(fluorescence intensity) of K17 
was significantly lowered in cells transfected with plasmid containing the seed sequence of K17 3’ 
UTR compared to vehicle groups(65.31%+6.32% and 54.18%+10.01% vs.100.00%,respectively, 
p<0.05). Further bioinformatics analysis revealed a potential SMADs binding motif in miR-486-3p. 
We therefore observed that the level of TGF-β receptor I and phosphor-SMAD3 were both reduced 
in psoriatic epidermis. Inhibition of SMAD3 phosphorylation in TGF-βstimulated keratinocytes by 
corresponding inhibitor or siRNA showed downregulation of miR-486-3p and restoration of K17 
expression. Finally, we applied miR-486-3p agomir on imiquimod-induced psoriasis-like mice and 
observed downregulation of K17 and the alleviation of psoriasis-like symptom. Taken together, 
we conclude that TGF-β signaling is declined in psoriasis, followed by downregulation of SMAD3 
phosphorylation and consequently mature of miR-486-3p, and finally leads to increase of K17 and 
disease progression. Our work therefore suggests a mechanism of regulation of “psoriatic keratin” 
K17 in the pathogenesis of psoriasis and provides a new effective strategy for psoriasis therapy.   
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IL-17A increases asymmetric stem cell divisions in imiquimod-induced psoriasis
G Vitcov1, 2, S Sklar1, 2, J North1, 3, S Arron1, 2, 4, K Horton,5 A Charruyer1, 2 and R Ghadially1, 
2 1 Dermatology, UCSF, San Francisco, CA, 2 Dermatology, VAMC, San Francisco, CA, 3 
Pathology, UCSF, San Francisco, CA, 4 Dermatologic Surgery, UCSF, San Francisco, CA and 
5 California Pacific Med Ctr, San Francisco, CA
Imiquimod is a TLR7/TLR8 ligand and potent immune activator. In humans and mice, imiquimod 
produces a psoriasis-like eruption. Imiquimod-induced psoriasis-like skin inflammation is mediated 
via the IL-23/IL-17 axis. Stem cells divide in 3 ways: asymmetric divisions leading to one stem cell 
and one transit amplifying cell and symmetric divisions leading either to two stem cells or to two 
transit amplifying cells. We previously found that keratinocytes from psoriasis showed increased 
asymmetric divisions compared with keratinocytes from non-lesional psoriasis and age/gender 
matched normal skin. We hypothesized that hyperproliferation in imiquimod –induced psoriasis in 
mice is associated with increased asymmetric stem cell divisions, mediated by an IL-17-dependent 
mechanism. Stem cell divisions were assessed using Numb and LGN (both present in the differ-
entiated cell of asymmetric divisions) immunofluorescence in keratinocytes and using alpha and 
gamma tubulin (present in microtubules) immunofluorescence in tissue sections. We found that in 
samples from human psoriasis there was an increased proportion of perpendicular/asymmetric stem 
cell divisions in the basal layer compared with control normal epidermis (59.7±3.5 vs. 41.1±4.9%, 
p<0.05, n=3). In mice with imiquimod-induced psoriasis-like skin eruption there was an increased 
proportion of perpendicular/asymmetric divisions compared with vehicle-treated controls (53.3 vs. 
22.7%, n=2). We further found that treatment of human keratinocytes in vitro with IL-17A increased 
the proportion of asymmetric stem cell divisions over controls (64±5 vs 37±3.4%, p<0.01, n=3), 
providing a mechanism for the increased proportion of asymmetric stem cell divisions seen with 
imiquimod treatment and in psoriasis. Understanding dysregulation of SC divisions in hyperpro-
liferative disorders will allow selection of appropriate agents to manipulate SC divisions for novel 
therapeutic approaches.    
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Discovery of natural products that provide multi-functional anti-aging skin benefits 
BC Mei,1 C Hwang,1 J Idkowiak-Baldys,2 D Thorn Leeson,1 U Santhanam3 and J Lyga1 1 
New Technology, Avon Products, Inc., Suffern, NY, 2 Cell Biology and In vitro Testing, Avon 
Products, Inc., Suffern, NY and 3 Clinical Efficacy, Avon Products, Inc., Suffern, NY
Avon Global R&D has had a concerted skincare active ingredient discovery program for over 30 
years. Due to the rich history of plant-based traditional medicine around the world, Avon has 
actively pursued identifying plants that can deliver skincare benefits to consumers. Through our 
research we have discovered that extracts of Tiliacora triandra, a climbing vine with a long history 
of culinary and medicinal use in Southeast Asia, has potential to be a potent skincare active ingre-
dient. In vitro bioassays show that extracts of Tiliacora triandra can stimulate glycosaminoglycan 
(GAG) productions as well as protect the extracellular matrix (ECM) from degradation by reducing 
protease activity. Upon placebo controlled in vivo testing, we’ve also observed its ability to pro-
mote epidermal proliferation and stimulate collagen production. Based on the in vitro and in vivo 
evidence, we believe our Tiliacora triandra extract has the potential to be a potent skincare active 
that can reduce the signs of aging.    
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A cosmetic formulation containing ingredients that stimulate in vitro production of epidermal 
differentiation proteins improves in vivo barrier function
G Kalahasti, H Pham, D Gan, TC Florence and MD Hines Skin & Clinical Research, Mary 
Kay, Dallas, TX
Proteins involved in epidermal differentiation are vital components of epidermal integrity that 
contribute to normal barrier function. Reduced expression of these proteins, such as filaggrin and 
occludin, has been noted in various skin diseases such as atopic dermatitis, allergic contact derma-
titis, dry skin and rosacea. Improving the function of the epidermal barrier has emerged as a new 
option for long term treatment of these skin conditions. Here, we identified four botanical extracts 
that upregulated the expression of filaggrin and occludin in cultured normal human epidermal 
keratinocytes. When combined, these extracts reduced epidermal permeability as demonstrated 
using a dye permeation assay on 3D skin models. A cosmetic formulation containing these extracts 
was created to evaluate their effectiveness on barrier function in vivo. Twenty five subjects with high 
trans-epidermal water loss (TEWL) values were recruited for a 3 week D-squame barrier challenge 
study. TEWL measurements were obtained at baseline prior to stripping and post stripping and 
were repeated again at the end of the treatment period. TEWL showed significant improvements 
in the skin barrier between the subjects treated with the cosmetic formulation and the untreated 
subjects. The stratum corneum (SC) of the treated sites was also less disrupted by mechanical insult. 
Skin surface hydration measurements (Skicon 200) showed that the conductance was significantly 
elevated when treated with the non-moisturizing cosmetic formulation. Clinical evaluations showed 
significant decreases in visual dryness and tactile roughness on Day 21 compared to baseline. In 
conclusion, the cosmetic formulation was highly effective in maintaining a healthy skin barrier with 
improvements in TEWL and tactile roughness of individuals with visual dry skin.    
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In vivo imaging and identification of the dermal-epidermal junction
V Newton,1 MJ Sherratt,2 R Bradley,3 AV Rawlings,4 R Voegeli,5 CE Griffiths1 and RE Watson1 
1 Centre for Dermatology Research, University of Manchester, Manchester, United 
Kingdom, 2 Centre for Tissue Injury & Repair, University of Manchester, Manchester, United 
Kingdom, 3 Material Sciences, University of Manchester, Manchester, United Kingdom, 
4 AVR Consulting Ltd, Northwich, United Kingdom and 5 DSM Nutritional Products Ltd, 
Kaiseraugst, Switzerland
We investigated whether confocal microscopy [CM], optical coherence tomography [OCT] & 
microcomputed tomography [microCT] imaging techniques could visualize the dermal-epidermal 
junction (DEJ) in sufficient detail to negate the need for skin biopsy. Forearm and buttock skin from 
volunteers (aged 18-30 or ≥65 yrs; n=10 per group) were imaged using CM (VivaScope® 1500, 
MAVIG GmbH, Germany) and/or OCT (Swept Source OCT System; Thorlabs LTD, UK). Furthermore, 
skin biopsies (6mm) were taken from each site and processed for microCT and histology. Using 
OCT, a superficial dark band was observed which was presumed to be the epidermis; although there 
was correlation between OCT data and epidermal thickness (measured on H&E-stained sections) 
these were not strong (r=0.6, p<0.01). DEJ visualisation in the form of dermal papillae was possible 
using CM, allowing differentiation of dermal papilla height in young compared to aged forearm skin 
(p<0.05); this measurement was difficult in photoprotected buttock due to reduced melanin content. 
MicroCT of unstained samples allowed visualization of DEJ but complete resolution in some areas 
was difficult. Addition of a contrast agent (Lugol’s; I2KI) improved visualization of the DEJ. Hence, 
although CM and OCT have the advantage of being non-invasive, uncertainty around the exact 
optical boundaries and low resolution in non-plantar skin made OCT problematic for DEJ visual-
ization. Greater resolution made CM a more useful tool, but the ability to visualize DEJ is reduced 
in skin of lighter phototypes. MicroCT allowed detailed visualization of the DEJ in 3D without the 
need for skin sectioning; use of a contrast agent was necessary for identification of the DEJ in an 
acceptable scan time. Therefore, histology still remains the gold standard for visualisation of the DEJ.   
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Targeted deletion of suprabasal keratins K2 and K10 causes upregulation of K1 and K16
H Fischer,1 L Langbein,2 S Praetzel-Wunder,2 J Reichelt,3 E Tschachler1 and L Eckhart1 1 
Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2 Department 
of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany 
and 3 Institute of Cellular Medicine and North East England Stem Cell Institute, Newcastle 
University, Newcastle upon Tyne, United Kingdom
Keratins K1, K2 and K10 are the main components of the cytoskeleton in keratinocytes of the supra-
basal epidermis. In the mouse K1 is absent from skin regions of the ears, soles and the tail where 
K2 is expressed. K1 and K2 heterodimerize with K10 to form intermediate filaments. To investigate 
the biological effects of genetic disturbances of the keratinocyte cytoskeleton, we have generated 
and characterized mice in which both K2 and K10 are inactivated by targeted gene deletions. Mice 
deficient for both K2 and K10 were viable but developed hyperkeratotic epidermis on their ears 
and soles. Protein extraction, electrophoresis and nano-HPLC ESI-MS/MS showed that K2 and K10 
were the most abundant proteins in corneocytes of the soles of wild type mice. The deletion of the 
Krt2 and Krt10 genes abolished these proteins and resulted in a massive increase in the amounts of 
K1 and K16. Immunofluorescence analysis confirmed that K1 and K16 accumulated in the supra-
basal layers of the epidermis of K2/K10-deficient mice, and quantitative reverse transcription-PCR 
demonstrated that K1 and K16 were upregulated at the mRNA level. In summary, this study suggests 
that the loss of the keratin pair K2/K10 is partly compensated by the upregulation of K1 and K16.   
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Biochemical changes underlying a keratoderma-like phenotype in mice lacking suprabasal 
AP1 transcription factor function
E Rorke,2 G Adhikary,1 C Young,1 RH Rice,3 PM Elias,4 D Crumrine,4 M Blumenberg5 and 
R Eckert1 1 Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD, 2 
Microbiology and Immunology, University of Maryland, Baltimore, MD, 3 Environmental 
Toxicology and Forensic Science, University of California, Davis, Davis, CA, 4 Dermatology, 
University of California, San Francisco, San Francisco, CA and 5 Dermatology, New York 
University, New York, NY
We have shown that suprabasal AP1 transcription factor activity is essential for normal epidermal 
differentiation, and that inactivation increases basal cell proliferation, enhances hyperkeratosis 
and parakeratosis, and delays differentiation. However, little is known regarding the structural and 
biochemical changes that drive this phenotype. EM images show markedly reduced formation of 
cornified envelopes (CE), keratohyalin granules, keratin filaments, and desmosomes; and reduced 
lamellar biolayer formation, premature lamellar body secretion. This is associated with reduced 
barrier integrity. Analysis of the cornified envelope proteome reveals a substantial reduction in fil-
aggrin, filaggrin2, late CE precursor protein and keratin-associated proteins - coupled with increased 
incorporation of desmosome linker, small proline-rich, S100, and inflammation-associated proteins. 
Incorporation of cutaneous keratins is reduced, and hyperproliferation-associated epidermal keratin 
incorporation is increased. RNA array analysis reveals reduced expression of mRNA encoding dif-
ferentiation-associated cutaneous keratins, late cornified envelope precursors and filaggrin-related 
proteins; and increased expression of mRNA encoding small proline-rich proteins, protease inhib-
itors, S100 proteins, defensins, and hyperproliferation-associated keratins. A particularly striking 
feature is a dramatic reduction in expression of hair keratin and associated proteins. These findings 
suggest that AP1 factors directly control expression of hair keratin and hair keratin associated protein 
and late markers of keratinocyte differentiation, and that other changes are indirect responses due 
to loss of normal differentiation progression.    
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Comparative genomics identifies filaggrin-deficient species of mammals
B Strasser, V Mlitz, H Fischer, E Tschachler and L Eckhart Department of Dermatology, 
Medical University of Vienna, Vienna, Austria
Filaggrin is a critical protein of the mammalian skin barrier. Deleterious mutations of the filaggrin 
(FLG) gene are associated with ichthyosis vulgaris and atopic dermatitis. To get insights into the 
biological roles of filaggrin, we determined the conservation or loss of FLG during the evolutionary 
adaptation of animals to distinct environments and lifestyles. By comparative genomics, we show 
that FLG is absent from non-mammalian species but conserved in phylogenetically diverse mam-
mals, indicating an evolutionary origin of filaggrin in primitive mammals after their evolutionary 
divergence from the lineage leading to modern reptiles. Among fully aquatic mammals, filaggrin 
has been lost in whales whereas it has been retained in dolphins. Both whales and dolphins have 
lost caspase-14, a protease implicated in the processing of filaggrin to components of the so-called 
natural moisturizing factor. The discordant evolution of filaggrin and caspase-14 indicates that 
the biological roles of these proteins are not strictly interdependent. Our results suggest that com-
parative genomics can complement gene knockout studies in mice to correlate gene deficiencies 
and skin phenotypes.    
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Calmodulin-like 5 interacts with 14-3-3-σ/stratifin to regulate late epidermal differentiation 
B Sun, J Ransohoff, K Qu, V Lopez-Pajares, LD Boxer and P Khavari Dermatology, Stanford 
University School of Medicine, Stanford, CA
Epidermal development and homeostasis requires stratification of keratinocytes from the basal to 
cornified layers, organized properly to form a multifunctional tissue. The molecular mechanisms that 
govern functional coordination between epithelial strata are still incompletely understood, and are 
central to understanding epidermal regeneration and repair. To identify potential novel regulators of 
this process, we examined candidate genes represented in differentiated layers of the epidermis that 
were also expressed in other stratified epithelial tissues. This analysis highlighted a potential role for 
calmodulin-like 5 (CALML5), a protein with homology to calmodulin that is upregulated >100-fold 
during epidermal differentiation, but whose function is incompletely understood. CALML5 controls 
expression of 517 genes, as determined by RNAi depletion and CRISPR/Cas9-mediated knockout of 
CALML5 in epidermal tissue. These genes include proteins dysregulated in human skin diseases and 
known to be vital to epidermal differentiation, such as structural proteins (FLG, LOR, LCE3D), lipid 
biosynthesis enzymes (ELOVL4, ALOXE3), and proteases & protease inhibitors (CASP14, SPINK5). 
Using gene set enrichment analysis, RNA interactome-seq, and ChIP-seq, we demonstrate that 
CALML5 is induced by the transcription factor ZNF750, and is post-transcriptionally regulated 
by the noncoding RNA TINCR. Proximity-dependent biotin ligation analysis was used to define 
the CALML5 interactome, which identified 14-3-3σ (stratifin) as a key CALML5 interactor whose 
depletion substantially phenocopies the differentiation defect observed with CALML5 loss. Taken 
together, these results describe a novel regulatory pathway for late epidermal differentiation that 
may be instrumental to skin development, renewal, and repair.    
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Histological stratification of thick and thin plaque psoriasis identifies distinct molecular and 
clinical phenotype
P Nadella,1 JM Corrêa da Rosa1, 2, J Kim,1 JG Krueger1 and M Suarez-Farinas1 1 Laboratory 
of Investigative Dermatology, Rockefeller University, New York, NY and 2 Center for Clinical 
and Translational Science, Rockefeller University, New York, NY
Each psoriasis patient’s molecular characteristics are different but there have been no studies yet to 
stratify clinical phenotypes into subclasses with meaningful differences in molecular phenotypes. In 
this study, we conducted phase V clinical research to test if histological measurement of epidermal 
thickness can stratify psoriasis patients into subgroups with different psoriasis transcriptome and 
treatment response to biologics. Using 609 psoriasis patients’ de-identified data at our tissue bank, 
we examined the distribution of histologically measured epidermal thickness. Two populations 
with distributions centered on different thickness values were identified by expectation maximiza-
tion algorithm, thus defining “thick” and “thin” plaque psoriasis histologically. In a cohort of 65 
moderate to severe plaque psoriasis patients, the stratification was immunohistologically validated 
by confirming different numbers of CD3+ T cells and CD11c+ dendritic cells in the tissue then 
comparing expression profiles between groups. Thick and thin plaque psoriasis share the psoriasis 
transcriptome but the expression levels were different. Interestingly, gene expression of thick and thin 
plaque psoriasis was not only different within psoriatic lesional skin but also different in peripheral 
non-lesional skin. Clinically, the severity of psoriasis measured by Psoriasis Area Severity Index 
(PASI) or Body Surface Area (BSA) was not different between thick vs. thin plaque psoriasis, but 
they showed different responses to Etanercept, Ustekinumab 45 mg and Ustekinumab 90 mg. To 
our knowledge, this is the first description correlating epidermal thickness, psoriasis transcriptome, 
and clinical responses to biologics.    
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Temporal variations in sirtuin expression under normal and ultraviolet B-induced conditions 
and their correlation to energy levels in normal human epidermal keratinocytes 
E Pelle1, 2, K Dong1 and N Pernodet1 1 R&D, Estee Lauder Inc., Melville, NY and 2 
Environmental Medicine, New York University School of Medicine, New York, NY
Sirtuins are post-translational modifiers that affect transcriptional signaling, metabolism, and DNA 
repair. Although originally identified as gene silencers capable of extending cell lifespan, the 
involvement of sirtuins in many different areas of cell biology has now become widespread. Our 
approach has been to study the temporal variation and also the effect of environmental stressors, 
such as UV and ozone, on sirtuin expression in normal human epidermal keratinocytes. Here, we 
measured the variation in expression of sirtuins 1 and 6, which are localized in the nucleus, and 
mitochondrial sirtuin 3 over time and also show how a low dose of UVB can affect this pattern 
of expression. Moreover, we correlated these changes to variations in ATP and H2O2 levels. Our 
data show significant variations in normal sirtuin expression which may indicate a generalized 
response by sirtuins to cell cycle kinetics. These results also demonstrate that sirtuins as a family of 
molecules are sensitive to UVB-induced disruption and show how low doses of UVB may quickly 
affect metabolic regulation and DNA repair. Taken together, these results further underscore the 
importance of protection against sun exposure and may suggest a new paradigm for determining 
environmental stress on aging.    
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Major differences between human atopic dermatitis phenotype and mouse models as deter-
mined by global genomic profiling
S Noda1, 2, DA Ewald1, 3, S Nakajima,4 T Litman,3 JG Krueger,1 M Suarez-Farinas,1 
K Kabashima4 and E Guttman-Yassky2 1 Laboratory of Investigative Dermatology, The 
Rockefeller University, New York, NY, 2 Department of Dermatology, Icahn School of 
Medicine at Mount Sinai, New York, NY, 3 Leo Pharma, Copenhagen, Denmark and 4 
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Atopic dermatitis (AD) is caused by a complex interplay between immune and epidermal barrier 
abnormalities. While many mouse models have been used to simulate lesional AD, their molecular 
phenotypes are not fully understood, and a comparison of key models to human AD is lacking. We 
sought to evaluate the molecular phenotype of common models and determine how these relate 
to human AD skin. Genomic profiling was performed using microarrays and RT-PCR on biopsies 
from 4 models, including the flaky tail, filaggrin-mutated (ma mutation is eliminated), ovalbu-
min-sensitized, and NC/Nga mice. Using criteria of >2 fold change (FCH), FDR<0.05, the mouse 
transcriptomes ranged from 618 differentially expressed genes (DEGs) in NC/Nga to only 66 DEGs 
in filaggrin-mutated mice. The highest overlap with the AD phenotype (595 DEGs) was observed 
for NC/Nga mice (118 genes;~20%), including several hyperplasia related (K16, Ki67, S100A) 
genes. NC/Nga mice demonstrated robust Th1, Th2, Th17 and innate immune activation with 
minimal Th22 induction, without reductions in differentiation genes (e.g filaggrin) as observed in 
AD. Ovalbumin-sensitized mice showed both epidermal (S100A) gene alterations and non-specific 
immune activation with the second highest gene-overlap with AD. Flaky-tail mice showed strong 
Th17 polarization and inhibition of differentiation genes, while filaggrin-mutated mice displayed 
barrier abnormalities alone. In sum, no single mouse model fully captures all aspects of the AD 
phenotype, but rather, each reflects different immune or barrier disease aspects. NC/Nga mice 
model some immune characteristics (lacking Th22 activation), while flaky tail and filaggrin-mutated 
mice show abnormal differentiation. Thus, the choice of mouse model depends on the translational 
focus of the investigation.    
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Analysis of CARD14 polymorphisms in pityriasis rubra pilaris: Activation of NF-kB
Q Li,1 H Chung,1 N Ross,1 MS Keller,1 J Andrews,1 J Kingman,1 O Sarig,2 D Fuchs-Telem,2 
E Sprecher2 and J Uitto1 1 Thomas Jefferson University, Philadelphia, PA and 2 Tel Aviv 
Sourasky Medical Center, Tel Aviv, Israel
Pityriasis rubra pilaris (PRP) is an inflammatory papulo-squamous disorder with no specific or 
uniformly effective treatment. Most cases are sporadic but a familial form with an AD inheritance 
with partial penetrance represents <6% of all cases. We recently demonstrated that patients with 
the familial PRP harbor mutations in the CARD14 gene encoding CARD14, an activator of nuclear 
factor kB (NF-kB). This study investigates whether CARD14 mutations might also underlie cases 
of sporadic PRP. A total of 156 patients with the diagnosis of PRP were enrolled in the study, and 
48 of them returned blood or saliva for DNA isolation. CARD14 was examined by sequencing of 
the exons and the flanking intronic sequences. We identified 15 sequence variants, many of which 
were neutral and none were nonsense mutations. A total of 8 missense mutations and 2 SNPs within 
the splice-junctions were evaluated by bioinformatics programs, as well as by comparison with 
the SNP databases. By this approach, 6 sequence variants were considered to be inconsequential 
polymorphisms, while 4 variants, present in the SNP database in allelic frequency of <1.5%, were 
considered pathogenic. One variant (c.599G>A; p.S200N) was present in 3 patients; thus a mutant 
CARD14 allele was present in 6 of 48 patients (12.5%). To examine the consequences of missense 
variants on the activation of NF-kB, in vitro assays were performed in a HeLa cell line which 
constitutively expresses low level of luciferase reporter under a NF-kB responsive element when 
transfected with a plasmid harboring CARD14 cDNA, either wild-type or mutant. In this system, only 
one variant (c.683T>G; p.L228R) was capable of up-regulation of the NF-kB responsive element. 
Since our studies on sporadic PRP have suggested that NF-kB signaling is activated in the epidermis, 
even in the absence of CARD14 mutations, it is plausible that mutations in other components of the 
CARD14 signaling cascade can result in activation of NF-kB.    
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Topical delivery of Hyaluronic acid in dermatomed human skin
P Bakshi and AK Banga Department of Pharmaceutical Sciences, College of Pharmacy, 
Mercer University, Atlanta, GA
Purpose: Skin aging is a very intricate process involving various mechanisms. One of the main factors 
responsible for aging is loss of moisture. The key molecule responsible for maintaining moisture 
in the skin is Hyaluronic acid (HA). However, the delivery of this hydrophilic macromolecule into 
skin has been questionable. In this study, different delivery techniques were investigated. Hyaluro-
nidase enzyme was used to neutralize endogenous HA and then microneedles and iontophoretic 
techniques were investigated to deliver HA into skin. Methods: Dermatomed human skin was 
treated with 200 units of sodium hyaluronidase and incubated at 37°C for 1 hour. Enzymatic activity 
was stopped by immersing the skin in PBS (pH 7.4) for few seconds at 60°C. In vitro permeation 
studies were done using vertical Franz diffusion cells. The receptor contained PBS buffer and the 
donor compartment contained 500ul (1mg/ml) of Sodium Hyaluronate (MW 15-30 kDa). Maltose 
microneedles (500μm) and anodal iontophoretic techniques were used on skin. Analysis was done 
using Hyaluronic acid ELISA kit. Results: The amount of endogenous HA present in human epidermis 
(0.30 ± 0.05μg/sq.cm) was reduced by enzymatic treatment (0.08 ± 0.03μg/sq.cm). Thus, enzyme 
treated skin was chosen as a blank control. The endogenous HA leaching out of the dermatomed 
human skin was 9.80 ± 0.7μg/sq.cm. Data normalized for endogenous HA delivered larger amount 
of HA in receptor (22.72 ± 3.8μg/sq.cm) for microporated skin as compared to passive delivery 
(13.40 ± 11.3μg/sq.cm). Similarly, the amount in dermis (10.92 ± 6.7μg/sq.cm) was higher for 
microporated skin compared to passive (4.01 ± 3.05μg/sq.cm). Iontophoresis resulted in highest 
delivery in epidermis (6.04 ± 1.5μg/sq.cm) compared to other techniques. Conclusion: Enzyme 
treated skin in combination with microneedles or iontophoresis enhanced the delivery of HA in 
dermatomed human skin.    
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Exploring the metabolome effectively to advance skincare research
T Shafizadeh Lipomics, LP, Metabolon, Inc., Durham, NC
Skin is a metabolic organ that provides a first line of defense against environmental, physical and 
chemical assaults. The architecture of human skin is complex and each layer possesses a metabolic 
signature with a unique composition and function. The cumulative impacts of environmental, phys-
ical, chemical, and microbiological stresses contribute to biochemical changes that are reflected 
in skin’s metabolome. Metabolomic analysis of skin has begun to elucidate biochemical changes 
associated various skin conditions, such as acne, atopic dermatitis and aging, and can be key to 
understanding such conditions. Here we describe discovery approaches designed to broadly survey 
the skin metabolome as well as focused metabolomic assessment of sebum, stratum corneum, skin 
biopsy, cell culture and reconstructed skin models across a variety of skin conditions. Understanding 
the unique biochemical composition and regulation of the skin metabolome provides insight into 
biomarker identification, response to intervention, and the development of therapeutic and skin 
care products across a variety of skin conditions.    
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Regulation of protein synthesis during keratinocyte differentiation
AE Collier,1 RC Wek1 and DF Spandau1, 2 1 Biochemistry & Molecular Biology, Indiana 
University School of Medicine, Indianapolis, IN and 2 Dermatology, Indiana University 
School of Medicine, Indianapolis, IN
In response to cellular stress, phosphorylation of eukaryotic initiation factor 2 (eIF2~P) is a key 
mechanism for control of general protein synthesis. Concurrent with repression of global translation 
initiation, eIF2~P preferentially enhances translation of cytoprotective gene transcripts, including the 
transcriptional activator ATF4 as well as the downstream pro-apoptotic transcription factor CHOP. 
Although this pathway is well characterized in response to most stressors including endoplasmic 
reticulum (ER) stress, the role of protein synthesis regulation during the formation of the epidermis 
is largely unknown. To investigate general protein synthesis during keratinocyte differentiation, we 
induced differentiation in vitro by adding 2mM Ca2+ to confluent keratinocytes for 5 days. Differ-
entiation caused a global reduction in protein synthesis levels as measured by polysome profiling, 
as well as induced eIF2~P in keratinocytes to levels similar to that seen following ER stress with 
tunicamycin. Differentiation also caused inhibition of mTOR, another factor involved in modulating 
levels of protein synthesis, to levels measured with rapamycin, a known mTOR inhibitor. Epidermal 
Differentiation Complex (EDC) transcripts including involucrin and loricrin were preferentially bound 
to large polysomes following differentiation, providing novel evidence for preferential translation 
of EDC genes whose regulation has been previously characterized primarily at the transcriptional 
level. Despite induction of eIF2~P and preferential translation of ATF4, downstream cellular stress 
targets ATF4 and CHOP mRNA levels were significantly reduced, suggesting that repression of 
stress-related genes is important for proper differentiation. These studies provide new evidence for 
modulation of protein synthesis as well as translational control of EDC genes during the normal 
process of keratinocyte differentiation, and could provide novel therapeutic targets for skin diseases 
in which the differentiation process is altered.    
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Topoisomerase 2β impacts gene-length bias in psoriasis through altered epidermal 
differentiation
MK Sarkar,1 A Johnston,1 WR Swindell,1 X Xing,1 A Finkielsztein,2 S Getsios2 and 
JE Gudjonsson1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2 Dermatology, 
Northwestern University, Chicago, IL
Psoriasis is a common chronic inflammatory skin disease that affects 2-3% of the US population 
and is characterized by skin plaques resulting from the hyper-proliferation and altered differenti-
ation of the epidermis. Understanding the mechanism behind this shift in epidermal function is 
crucial for developing improved targeted therapies. Using RNAseq we observed that these changes 
are accompanied by shifts in the lengths of expressed genes, with the expression of short genes 
increased and long genes decreased (p=1.4E-15). This length bias was rapidly reversed by 1wk of 
anti-TNF therapy (p<.05). We confirmed our findings using qPCR of representative short and long 
genes in psoriatic skin (n=8, p=6.0E-04). Comparison of nuclear and cytoplasmic mRNA expression 
demonstrated that these shifts were due to transcriptional regulation. To understand the link between 
gene length and epidermal differentiation status we examined primary KC cultures and epidermal 
raft development and observed an increase in long genes with differentiation (n=3, p=6.5E-11). 
Topoisomerases (TOPs) facilitate the transcription of long genes, thus we examined the expression 
of TOPs in KC and psoriasis skin. We found expression of TOP2B mRNA correlated with that of 
differentiation markers (IVL) in cultured KC, and was decreased in psoriatic compared to normal skin 
(n=8, FC<.5, p=2.0E-4). Use of a specific TOP2β inhibitor (ICRF-193) at an early stage in epidermal 
raft development prevented epidermis formation, but later exposures led to altered differentiation 
and a decrease in long gene expression (n=3, p<.05). This was replicated in ex-vivo skin organ 
cultures (n=4, p<.0004). This indicates that TOP2β stabilization of long gene expression and epi-
dermal differentiation are tightly linked, and that inflammation in psoriasis is intrinsically linked 
to this process. Further exploration of this process to determine its role in regulating inflammatory 
responses could lead to novel therapeutic approaches in psoriasis.    
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Ingredients and formulation that improve barrier function also enhance antimicrobial peptide 
production
R Sun, M Man, M Hupe, J Wakefield and PM Elias Dermatology, UCSF/VA Medical Ctr, San 
Francisco, CA
Prior studies have shown first, that permeability barrier homeostasis and cutaneous antimicrobial 
defense are co-regulated and interdependent functions. We recently demonstrated that expression 
of the mouse analogue of the epidermal antimicrobial peptide (AMP), cathelicidin (mCRAMP – 
homologue of LL-37), and to a lesser extent, human b-defensin (hBD) and catestatin expression, 
decline in parallel with compromised barrier function with skin aging, during psychological stress, 
and following erythemogenic doses of UV-B. Here, we explored the opposite scenario; i.e., whether 
ingredients or formulations that reportedly improve barrier homeostasis also enhance epidermal 
AMP expression. Several individual ingredients, such as topical urea, and PPAR/LXR activators, 
as well as herbal ingredients, such as apigenin, and a ceramide-dominant, triple-lipid mixture of 
cholesterol, free fatty acids, and ceramides (EpiCeram® emulsion) accelerated barrier repair in 
normal epidermis. In contrast, several other putative ‘barrier repair’ formulations displayed no net 
benefits, or delayed barrier recovery after acute insults to either human or mouse skin. Each of the 
ingredients that enhanced barrier function also stimulated mCRAMP/LL-37 expression in parallel, 
with EpiCeram stimulating a significant increase (p < 0.001) in LL-37, and a lesser increase in hBD2 
expression that did not achieve statistical significance. These results further demonstrate the close 
relationship between permeability barrier function and epidermal antimicrobial defense, and show 
that an effective barrier repair formulation promotes cutaneous antimicrobial defense in parallel 
with enhanced barrier function.    
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Improved differentiation of keratinocytes from human induced pluripotent stem cells by 
manipulation of developmental signaling pathways
Z Guo,1 C Shen,2 K Gledhill,1 A Coffman,1 S Shinkuma,1 N Umegaki-Arao,1 HE Abaci,1 
C Higgins,1 B Gillette,2 SK Sia2 and A Christiano1, 3 1 Dermatology, Columbia University, 
New York, NY, 2 Biomedical Engineering, Columbia University, New York, NY and 3 
Genetics and Development, Columbia University, New York, NY
Induced pluripotent stem cells (iPSCs) have enormous potential for cell therapy and disease modeling 
by providing unlimited number of cells. Realization of this potential is limited by the capacity to 
efficiently generate desired cell lineages. Several protocols have been developed to differentiate 
keratinocytes from human iPSCs and/or embryonic stem cells (ESCs). However, there is variation 
between different iPSC and ESCs lines to obtain stable mature keratinocytes from human pluripotent 
stem cells. It has been reported that treatment with transforming growth factor β (TGF-β) inhibitor 
(SB431542) increases keratinocyte differentiation efficiency from iPSCs, and that p63 protein level 
can be stabilized by perturbation of Wnt or Notch signaling pathways. In our previous studies, we 
successfully differentiated keratinocytes from iPSCs generated with retroviral transduction. Here, we 
continued these efforts and manipulated the Wnt, TGF-β and Notch signaling pathways to enhance 
keratinocyte differentiation from integration-free iPSCs. Specifically, iPSCs were generated from 
human fibroblasts by introduction of episomal vectors containing defined transcription factors. 
Keratinocyte differentiation was initiated under feeder-free conditions by treatment with the TGF-β 
inhibitor (SB431542), bone morphogenetic protein 4 (BMP 4) and retinoic acid. Subsequent admin-
istration of small molecules (IPW-2, SB431542 or DAPT) for 7 days to perturb Wnt, TGF-β or Notch 
signaling pathways stabilized p63 protein, and resulted in mature keratinocytes. Development of this 
protocol allows us to obtain large quantities of keratinocytes from iPSCs by manipulating signaling 
pathways that are involved in keratinocyte differentiation under in vivo conditions.    
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Psoriasis severity is increased by alcohol abuse: An animal model of alcohol abuse and 
psoriasis
RM Brand1, 2, M Paglia2 and LD Falo2, 3, 4 1 Department of Medicine, University of Pittsburgh, 
Pittsburgh, PA, 2 Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, 3 
Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA and 4 
Bioengineering, University of Pittsburgh, Pittsburgh, PA
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the population 
and 15% of alcoholics with liver disease. While some epidemiologic studies have revealed an inde-
pendent correlation between alcohol use and increased incidence of psoriasis, the high variability 
in alcohol usage and other confounding factors make these studies difficult to interpret. Since even 
moderately severe psoriasis can negatively impact everyday life, the emotional stress generated by 
psoriasis complicates these studies, as it is not obvious whether alcohol use augments psoriasis 
severity or whether the psychosocial components of psoriasis generate the alcohol abuse. To address 
this question in a controlled animal model environment, we combined a classic alcohol ingestion 
model with a well-established murine model of psoriasis to develop a controlled environment to 
determine whether alcohol consumption augments the severity of psoriasis. Using clinical assess-
ments we found that chronic alcohol ingestion worsens skin barrier disruption, increases erythema 
and inflammatory responses as well as epidermal hyperplasia normally associated with psoriasis. 
Disease onset occurred more rapidly and skin barrier disruption resolved more slowly. These studies 
support the hypothesis that heavy alcohol use biologically aggravates psoriasis pathogenesis. The 
association of psoriasis and alcoholism represents a major psycho-dermatological problem where 
a multidisciplinary treatment approach (including dermatologist, psychiatrist, psychologist and 
others) may improve patient outcomes.    
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Regulation of aquaporin-3 levels in epidermal keratinocytes through histone deacetylase 
inhibition
WB Bollag1, 2, V Choudhary1, 2, K Kagha2 and L Olala1, 2 1 Research, Charlie Norwood VA 
Medical Center, Augusta, GA and 2 Physiology, Georgia Regents University, Augusta, GA
Aquaporin-3 (AQP3) is a water and glycerol channel involved in normal epidermal function, 
including wound healing and barrier recovery. Data from Verkman’s group have demonstrated an 
epidermal phenotype in AQP3 knockout mice, and we and others have previously found aberrant 
AQP3 immunoreactivity in multiple human skin diseases. Thus, AQP3 has a key function in skin 
under both physiological and pathophysiological conditions; hence evaluating the regulatory mech-
anisms of AQP3 expression is critical. Our laboratory also demonstrated that AQP3 re-expression 
can induce differentiation in AQP3 knockout keratinocytes, suggesting AQP3 as a potential target 
for skin disorders characterized by abnormal keratinocyte differentiation. Here we show that a 
broad-spectrum histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA) can 
induce AQP3 mRNA and protein expression in a dose- and time-dependent manner. In addition, 
SAHA increased glycerol uptake in wild-type but not AQP3 knockout keratinocytes. Since the HDAC 
family is large, we next sought to identify the particular HDAC involved in AQP3 up-regulation, 
as well as to determine the mechanism by which HDAC inhibition regulates AQP3 expression. 
Normal mouse and human keratinocytes were treated with a panel of HDAC inhibitors, and the 
levels of AQP3 were determined by western analysis. Several of the HDAC inhibitors increased 
AQP3 levels in mouse and human keratinocytes, whereas others did not, allowing us to narrow the 
field in terms of the HDAC family member(s) likely to be involved in the regulation of AQP3 levels. 
In addition, we examined the possible role of p53 in the HDAC inhibitor-induced up-regulation of 
AQP3 and we found that overexpression of p53 enhanced, and the p53 inhibitor pifithrin impeded, 
the up-regulation in AQP3 levels elicited by HDAC inhibition. Thus, our study provides insight into 
the mechanisms regulating AQP3 expression and may allow the development of targeted therapies 
to treat skin diseases characterized by aberrant AQP3 expression.    
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Novel insights in the mechanisms of epidermal maintenance by in vivo imaging
P Rompolas and V Greco Genetics/Dermatology, Yale University School of Medicine, New 
Haven, CT
Maintenance and regeneration of the skin is achieved through a balanced process of self-renewal 
and differentiation. The epidermis consists of consecutive layers of epithelial cells at various states 
of differentiation, which originate from proliferative basal cells. It is currently not clear how indi-
vidual basal cells exit the cell cycle and commit to differentiation and how the process is regulated 
to maintain homeostasis at the tissue level. A challenge in directly answering these questions has 
been the inability to visualize and monitor the behavior of single cells in intact interfollicular epi-
dermis over long term. To address this, we have devised a novel approach by combining intravital 
microscopy with genetic lineage tracing tools, which enables us to mark single cells in the mouse 
epidermis and re-visit the same cells in order to monitor their differentiation state and contribution 
to epidermal maintenance over time. Thus, we have captured the behavior of epidermal cells in 
vivo and uncovered three populations with distinct fate characteristics. Specifically, the majority 
of the basal clones commit to terminal differentiation, either directly or following a limited number 
of cell divisions. Once committed, cells transit independently through the successive epidermal 
layers before they are ultimately shed from the skin. Basal clones that retain long-term proliferative 
capacity cycle rapidly while generating committed cells in the process. Strikingly, we found that 
the size of these clones fluctuates significantly in short term. Furthermore, the plane of epidermal 
cell divisions and expression pattern of early differentiation markers suggest that commitment to 
differentiation occurs while cells are still basally localized. Taken together, these data show that 
epidermal homeostasis is achieved through distinct but tightly regulated cellular behaviors and 
provide critical insight into the molecular mechanisms behind these processes. This study may also 
serve as a model for elucidating the biological basis of prevalent human skin diseases.    
      
